<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="description" content="crmPack">
<title>Model-based Dose Escalation Designs in R with crmPack (JSS manuscript) • crmPack</title>
<!-- favicons --><link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
<link rel="apple-touch-icon" type="image/png" sizes="180x180" href="../apple-touch-icon.png">
<link rel="apple-touch-icon" type="image/png" sizes="120x120" href="../apple-touch-icon-120x120.png">
<link rel="apple-touch-icon" type="image/png" sizes="76x76" href="../apple-touch-icon-76x76.png">
<link rel="apple-touch-icon" type="image/png" sizes="60x60" href="../apple-touch-icon-60x60.png">
<script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet">
<script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous">
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous">
<!-- bootstrap-toc --><script src="https://cdn.jsdelivr.net/gh/afeld/bootstrap-toc@v1.0.1/dist/bootstrap-toc.min.js" integrity="sha256-4veVQbu7//Lk5TSmc7YV48MxtMy98e26cf5MrgZYnwo=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.11/clipboard.min.js" integrity="sha512-7O5pXpc0oCRrxk8RUfDYFgn0nO1t+jLuIOQdOMRp4APB7uZ4vSjspzp5y6YDtDs4VzUSTbWzBFZ/LKJhnyFOKw==" crossorigin="anonymous" referrerpolicy="no-referrer"></script><!-- search --><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Model-based Dose Escalation Designs in R with crmPack (JSS manuscript)">
<meta property="og:description" content="crmPack">
<meta property="og:image" content="https://openpharma.github.io/crmPack/logo.png">
<!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]-->
</head>
<body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>
    

    <nav class="navbar fixed-top navbar-default navbar-expand-lg bg-primary" data-bs-theme="default"><div class="container">
    
    <a class="navbar-brand me-2" href="../index.html">crmPack</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">2.0.0.9155</small>

    
    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto">
<li class="nav-item">
  <a class="nav-link" href="../reference/index.html">Reference</a>
</li>
<li class="active nav-item dropdown">
  <a href="#" class="nav-link dropdown-toggle" data-bs-toggle="dropdown" role="button" aria-expanded="false" aria-haspopup="true" id="dropdown-articles">Articles</a>
  <div class="dropdown-menu" aria-labelledby="dropdown-articles">
    <a class="dropdown-item" href="../articles/trial_definition.html">Trial Definition</a>
    <a class="dropdown-item" href="../articles/trial_analysis.html">Trial Analysis</a>
    <a class="dropdown-item" href="../articles/trial_sanity_checks.html">Trial Design: basic sanity checks</a>
    <a class="dropdown-item" href="../articles/trial_simulation.html">Trial Simulation</a>
    <a class="dropdown-item" href="../articles/ordinal-crm.html">Ordinal CRM</a>
    <a class="dropdown-item" href="../articles/rolling-crm.html">Rolling CRM Example</a>
    <a class="dropdown-item" href="../articles/simulations.html">Simulation study example</a>
    <a class="dropdown-item" href="../articles/knit_print.html">Describing `crmPack` Objects</a>
    <a class="dropdown-item" href="../articles/tidy_method.html">Using tidy</a>
    <a class="dropdown-item" href="../articles/migration_from_the_old_crmPack.html">Migrating from crmPack version 1.0.3</a>
    <a class="dropdown-item" href="../articles/parallel_computing_with_extensions.html">Parallel computing with extensions</a>
    <a class="dropdown-item" href="../articles/crmPack-jss-paper.html">Model-based Dose Escalation Designs in R with crmPack (JSS manuscript)</a>
    <a class="dropdown-item" href="../articles/example.html">crmPack: Object-oriented implementation of CRM designs</a>
  </div>
</li>
<li class="nav-item">
  <a class="nav-link" href="../news/index.html">Changelog</a>
</li>
<!-- start dropdown for versions --> <li class="nav-item dropdown">
        <a href="#" class="nav-link dropdown-toggle"
          data-bs-toggle="dropdown" role="button"
          aria-expanded="false" aria-haspopup="true"
          id="dropdown-versions">Versions</a> <div class="dropdown-menu" aria-labelledby="dropdown-versions"> <a class="dropdown-item" data-toggle="tooltip" title="" href="https://openpharma.github.io/crmPack/main">main</a> </div></li>
<!-- end dropdown for versions -->
<li class="nav-item dropdown">
  <a href="#" class="nav-link dropdown-toggle" data-bs-toggle="dropdown" role="button" aria-expanded="false" aria-haspopup="true" id="dropdown-reports">Reports</a>
  <div class="dropdown-menu" aria-labelledby="dropdown-reports">
    <a class="dropdown-item" href="../coverage-report/">Coverage report</a>
    <a class="dropdown-item" href="../unit-test-report/">Unit test report</a>
  </div>
</li>
      </ul>
<form class="form-inline my-2 my-lg-0" role="search">
        <input type="search" class="form-control me-sm-2" aria-label="Toggle navigation" name="search-input" data-search-index="../search.json" id="search-input" placeholder="Search for" autocomplete="off">
</form>

      <ul class="navbar-nav">
<li class="nav-item">
  <a class="external-link nav-link" href="https://github.com/openpharma/crmPack">
    <span class="fa fa-github"></span>
     
  </a>
</li>
      </ul>
</div>

    
  </div>
</nav><div class="container template-article">




<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="../logo.png" class="logo" alt=""><h1>Model-based Dose Escalation Designs in R with crmPack (JSS manuscript)</h1>
            
      
      <small class="dont-index">Source: <a href="https://github.com/openpharma/crmPack/blob/HEAD/vignettes/crmPack-jss-paper.Rmd" class="external-link"><code>vignettes/crmPack-jss-paper.Rmd</code></a></small>
      <div class="d-none name"><code>crmPack-jss-paper.Rmd</code></div>
    </div>

    
    
<div class="section level2">
<h2 id="abstract">Abstract<a class="anchor" aria-label="anchor" href="#abstract"></a>
</h2>
<p>Model-based dose escalation designs have gained increasing interest
due to the need for more efficient and informative Phase I trials. The
wide-spread implementation of such designs has been hindered by the need
for either licensing specialized commercial software or programming the
design and simulations from scratch for each project. The
<code>R</code>-package <code>crmPack</code> provides a simple and
unified object-oriented framework for model-based dose escalation
designs. This enables the standard use of such designs, while being able
to flexibly adapt and extend them. The framework comprises classes and
methods for the data structure including the dose grid, statistical
models including prior specification, rules for maximum increments, next
best dose, and adaptive stopping and cohort sizes. In addition to
multiple modified classic continual reassessment method and escalation
with overdose control designs with possibly advanced prior
specifications (e.g., minimal informative and mixture priors),
<code>crmPack</code> currently features dual-endpoint (safety and
biomarker) designs and two-part designs. Optional assignment of a small
number of patients in each cohort to placebo instead of treatment
enables the use in trials outside Oncology.</p>
<p><em>Keywords</em>: continual reassessment method, model based dose
escalation, dual-endpoint design, R, object oriented.</p>
</div>
<div class="section level2">
<h2 id="introduction">Introduction<a class="anchor" aria-label="anchor" href="#introduction"></a>
</h2>
<p>Phase I trials that are testing new investigational agents in humans
for the first time escalate from low to high doses in a sequential
fashion. This dose escalation design is necessary in order to reduce the
risk of too high and therefore too toxic doses for the probands. These
can either be healthy volunteers (e.g., in neurology) or patients (e.g.,
in oncology), and we will henceforth use only the latter for ease of
presentation. While higher doses of agents are usually expected to
deliver stronger pharmacodynamic effects and hence improved efficacy,
higher doses also usually cause more severe adverse events in the
patients. In order to simplify the decision making usually binary
dose-limiting toxicities (DLTs) are defined (e.g., adverse events
reaching specific severity levels) before starting the trial. The
maximum tolerated dose (MTD) is then defined as the dose with a certain
probability of DLTs (either using a single value, e.g., 33%, or a range,
e.g., 20 to 35%). Historically, patients were treated at the same dose
in cohorts of three, with the dose for the next cohort then being
determined from the number of DLTs having been observed in the current
cohort.</p>
<p>Algorithmic designs like the simple 3+3 design <span class="citation">(Carter 1973)</span> have disadvantages that have been
recognized in the statistics community, see e.g., <span class="citation">(Paoletti, Ezzalfani, and Le Tourneau 2015)</span>.
Fundamentally, the escalation rules of the 3+3 design do not have any
statistical justification <span class="citation">(Storer 1989)</span> in
terms of estimating an MTD. Moreover, they cannot be extended to address
today’s Phase I trials, with extension cohorts, dose escalation of drug
combinations and optimal biological dose determination, naming just a
few prominent challenges. Hence model-based dose escalation designs like
the continual reassessment method (CRM) <span class="citation">(O’Quigley, Pepe, and Fisher 1990)</span> have gained
increasing interest due to the need for more efficient and informative
Phase I trials. These designs are based in statistical inference, with
dose-toxicity regression models as the backbone, and are therefore
flexible for adaptation to various complex trial designs. Importantly,
they avoid fixing only a few dose levels in advance. For a wider
comparison of algorithmic and model based designs see e.g., <span class="citation">(Jaki, Clive, and Weir 2013)</span>.</p>
<p>However, the wide-spread implementation of such designs has been
hindered by the need for either licensing specialized commercial
software (thus losing flexibility) or programming the design and
simulations from scratch for each project (thus losing efficiency).
While the models underlying most model-based dose escalation procedures
can easily be fit in standard software with the capability to fit
generalized linear models, e.g., <code>PROC MIXED</code> in
<code>SAS</code> <span class="citation">( Institute Inc. 2003)</span>,
<code>glm</code> in <code>Stata</code> <span class="citation">(StataCorp
2015)</span> or <code>R</code> <span class="citation">( Core Team
2016)</span>, there are still only few software solutions available
dedicated to dose escalation studies.</p>
<p>The commercial packages <code>East</code> <span class="citation">(Cytel Inc. 2016)</span> and <code>ADDPLAN</code> <span class="citation">(ICON Plc 2016)</span> both offer extensions to their
basic design software for dose escalation studies (<code>ESCALATE</code>
in <code>East</code> and <code>df</code> in <code>ADDPLAN</code>)
implementing the algorithmic 3+3 design and various versions of the CRM.
Similarly <code>FACTS</code> <span class="citation">(FACTS Development
Team 2015)</span> also offers different common dose escalation methods.
Due to the commercial nature of these implementations there is, however,
a limitation on how much the designs can be tailored towards the
individual needs of the study. Similarly static implementations of
methods for dose escalation are available in the <code>Stata</code>
module <code>crm</code> <span class="citation">(Mander 2013)</span>
which implements the CRM and the <code>dfcrm</code> package <span class="citation">(K. Cheung 2013)</span> in <code>R</code> which
additionally implements the time-to-event CRM (TITE-CRM) <span class="citation">(Y. K. Cheung and Chappell 2000)</span>. Several
<code>R</code>-packages with extensions are available. The
<code>bcrm</code> package <span class="citation">(M. Sweeting, Mander,
and Sabin 2013)</span> implements a variety of one and two parameter
models, and facilitates different ways to specify prior distributions,
escalation and stopping rules. The <code>ordcrm</code> package <span class="citation">(Dressler and Huang 2016)</span> implements ordinal
proportional odds and continuation ratio models for CRMs. The
<code>dfpk</code> package <span class="citation">(Toumazi, Ursino, and
Zohar 2017)</span> uses pharmacokinetic data in the dose escalation.</p>
<p>In this paper we introduce the <code>R</code>-package
<code>crmPack</code> <span class="citation">(Sabanes Bove et al.
2018)</span> for dose escalation studies, which is publicly available on
CRAN. While the package’s name pays tribute to the original CRM as the
first model-based dose escalation design, the package’s functionality
differs from the above existing implementations in three fundamental
ways. Firstly, it is written using <code>S4</code> classes and methods
<span class="citation">(Chambers 2008)</span>, which allows customized
methodology to be added to the package while still being able to use the
existing backbone functionalities. Secondly, methods for studies with a
placebo group (e.g., for healthy volunteer studies) are readily
implemented. Thirdly, dual endpoint dose escalation methods that
incorporate both safety and efficacy and allow determination of an
optimal biological dose are already available.</p>
</div>
<div class="section level2">
<h2 id="framework">Framework<a class="anchor" aria-label="anchor" href="#framework"></a>
</h2>
<p>For describing the framework of the package we will adapt the general
notation for early phase trials from <span class="citation">(Thall
2010)</span>. Figure @ref(fig:schematic) summarizes the framework in a
schematic.</p>
<div class="sourceCode" id="cb1"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu">knitr</span><span class="fu">::</span><span class="fu"><a href="https://rdrr.io/pkg/knitr/man/include_graphics.html" class="external-link">include_graphics</a></span><span class="op">(</span><span class="st">"./schematic.png"</span><span class="op">)</span></span></code></pre></div>
<div class="figure" style="text-align: center">
<img src="schematic.png" alt="Schematic of the framework" width="700px" height="540px"><p class="caption">
Schematic of the framework
</p>
</div>
<p>Separate design features are implemented as classes (shown as gray
boxes) and bundled together in the overarching <code>Design</code>
object. They can be processed with various methods (blue text) to run
the dose escalation trial and produce results (blue boxes). For example,
the <code>Data</code> and <code>GeneralModel</code> objects can be
processed by the <code>mcmc</code> method in order to obtain posterior
samples of the model parameters, and given the sample size and the dose
for the next cohort, the updated <code>Data</code> closes the dose
escalation loop. On the higher level, designs can be investigated with
the <code>examine</code> and <code>simulate</code> methods to obtain
hypothetical trial courses and operating characteristics, respectively.
Note that individual model classes and methods are not shown here for
clarity, please refer to the package documentation for details, e.g., by
calling <code><a href="../reference/crmPackHelp.html">crmPackHelp()</a></code>.’</p>
<p><strong>Data</strong> Let <span class="math inline">\(x\)</span>
denote one specific treatment, chosen from the set of possible
treatments <span class="math inline">\({\cal X}\)</span>. This could be
one specific dose, but also more generally a vector, containing for
example doses of multiple drugs in a combination trial. After giving
treatment <span class="math inline">\(x\)</span> to a patient, the
outcome <span class="math inline">\(y\)</span> is observed, typically a
safety endpoint as e.g., the binary DLT <span class="math inline">\(y
\in \{0,
1\}\)</span>. Grouping together <span class="math inline">\(n_{j}\)</span> patients in cohort <span class="math inline">\(j\)</span>, generating the cohort <span class="math inline">\(j\)</span> data <span class="math inline">\({\cal
C}_{j} = \{(x_{j}, y_{j,1}), \dotsc, (x_{j},
y_{j,n_{j}})\}\)</span>, we can denote the data generated from the first
<span class="math inline">\(N\)</span> cohorts as <span class="math inline">\({\cal D}_{N}= {\cal C}_{1} \cup \dotsb \cup {\cal
C}_{N}\)</span>.</p>
<p>In <code>crmPack</code> the <code>S4</code> class
<code>GeneralData</code> encapsulates this notion and subclasses
implement concrete data structures.</p>
<p><strong>Model</strong> The core of model-based dose escalation
designs is the underlying statistical model. Taking a Bayesian approach
to inference, the model in <code>crmPack</code> consists of firstly the
likelihood, which is either a probability density function <span class="math display">\[ f(y | x,
\theta)\]</span> or a probability mass function <span class="math display">\[ Prob(Y=y | x, \theta)\]</span> of <span class="math inline">\(y\)</span> for a patient who receives treatment
<span class="math inline">\(x\)</span> assuming the parameter (vector)
<span class="math inline">\(\theta\)</span>, (this is the likelihood of
<span class="math inline">\(\theta\)</span>) and secondly the prior
<span class="math display">\[ p(\theta | \xi)\]</span> for <span class="math inline">\(\theta\)</span> given fixed hyperparameters <span class="math inline">\(\xi\)</span>.</p>
<p>In <code>crmPack</code> the virtual <code>S4</code> class
<code>GeneralModel</code> encapsulates this notion and subclasses
implement concrete models.</p>
<p>For example, the class <code>LogisticLogNormal</code> implements the
logistic regression model <span class="citation">(Neuenschwander,
Branson, and Gsponer 2008)</span> with <span class="math display">\[\begin{equation}
\label{eq:LogisticLogNormal}
\mathrm{logit}(Prob(Y=1 | x,\theta))
\equiv \mathrm{logit}(\pi(x,\theta))
= \alpha_{0} + \alpha_{1} \log\left(\frac{x}{x^*}\right),
\end{equation}\]</span> parameter vector <span class="math inline">\(\theta = (\alpha_{0},\alpha_{1})\)</span>, dose
<span class="math inline">\(x &gt; 0\)</span> and specified reference
dose <span class="math inline">\(x^{*}\)</span>. The prior <span class="math inline">\(p(\theta | \xi)\)</span> is specified via a
bivariate normal distribution on a transformation of <span class="math inline">\(\theta\)</span> to ensure <span class="math inline">\(\alpha_{1} &gt; 0\)</span>: <span class="math display">\[\begin{equation}
  \label{eq:bivariateNormal}
  (\alpha_{0}, \log(\alpha_{1})) | \xi \sim \mathcal{N}_{2} (\mu,
\Sigma)
\end{equation}\]</span> with hyperparameters <span class="math inline">\(\xi = (\mu, \Sigma)\)</span> consisting of the
prior mean vector <span class="math inline">\(\mu\)</span> and the prior
covariance matrix <span class="math inline">\(\Sigma\)</span>.</p>
<p><strong>Decision making for the next dose</strong> Another core
element of a dose escalation design concerns the decision making for the
next dose <span class="math inline">\(x_{N+1}\)</span> to be tested in
the next cohort <span class="math inline">\(N+1\)</span>. In the <span class="citation">(Thall 2010)</span> notation, the function <span class="math inline">\(\alpha\)</span> is mapping the currently
accumulated data <span class="math inline">\(\mathcal{D}_{N}\)</span> to
the dose space <span class="math inline">\(\mathcal{X}\)</span> (or to
dose <span class="math inline">\(0\)</span>, meaning to stop the trial
because all doses are too toxic): <span class="math display">\[\begin{equation}
\alpha: {\cal D}_{N} \rightarrow \mathcal{X} \cup \{0\}
\end{equation}\]</span> This mapping is commonly specified via the
combination of two elements: The first element is a function <span class="math inline">\(\tau\)</span> for the maximum increments between
dose levels, which can calculate from the current data <span class="math inline">\(\mathcal{D}_{N}\)</span> (including the current
dose <span class="math inline">\(x_{N}\)</span>) the maximum possible
next dose <span class="math inline">\(t_{N+1}=\tau(\mathcal{D}_{N})\)</span> for the
next cohort. The second element is a rule <span class="math inline">\(\nu\)</span> indirectly acting on the current data
through the posterior distribution <span class="math inline">\(p(\theta
|
\mathcal{D}_{N})\)</span> and the maximum possible dose <span class="math inline">\(t_{N+1}\)</span> to finally give the next dose
<span class="math inline">\(x_{N+1} = \nu(p(\theta | \mathcal{D}_{N}),
t_{N+1})\)</span>.</p>
<p>In <code>crmPack</code> maximum increments are specified by
subclasses of <code>Increments</code>, and the next best dose rule by
subclasses of <code>NextBest</code>.</p>
<p><strong>The design class</strong> Additional features of a design
concern the adaptive sizing of the next cohort and the adaptive stopping
of the trial. Those are implemented in subclasses of
<code>CohortSize</code> and <code>Stopping</code>, respectively.
Moreover, the starting dose <span class="math inline">\(x_{1}\)</span>
is also a feature of the design.</p>
<p>Finally, the overall dose escalation design is bundling all the
described features together in a dedicated class typically inheriting
from <code>Design</code>.</p>
<p>As noted in <span class="citation">(Thall 2010)</span>, the operating
characteristics of such a complex dose escalation design can only be
evaluated by simulations. This can be done using the
<code>simulate</code> methods for the design classes, and is recommended
to be performed for a multitude of different scenarios in order to
stress-test the design and to convince oneself of its properties.</p>
<p>In particular, the operating characteristics reveal whether the MTD
can be estimated well by the designs.</p>
<p>In addition, the <code>examine</code> method evaluates hypothetical
trial outcomes and lists the resulting trial decisions (dose for the
next cohort and trial end).</p>
<p>In order to illustrate the use of this object-oriented framework, the
next section contains practical examples on use of the existing
functionality as well as an example for creating new extensions.</p>
</div>
<div class="section level2">
<h2 id="using-crmpack">Using crmPack<a class="anchor" aria-label="anchor" href="#using-crmpack"></a>
</h2>
<p>We consider a trial in Type II diabetes carried out by Hoffmann-La
Roche Ltd. in order to illustrate the functionality in the package. For
each patient, we observed a binary safety (DLT) and a continuous
efficacy outcome. In <a href="#implementing-a-crm-trial">Implementing a
CRM trial</a> we will show how to implement a CRM design for dose
escalation based on the safety endpoint only, while in <a href="#dose-escalation-with-safety-and-efficacy">Dose escalation with
safety and efficacy</a> also the efficacy endpoint will be considered.
<a href="#extending-crmpack-functionality">Extending crmPack
functionality</a> gives an example on extending the <code>crmPack</code>
functionality.</p>
<p>Before we start, we have to install and subsequently load our package
in <code>R</code>:</p>
<div class="sourceCode" id="cb2"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="kw"><a href="https://rdrr.io/r/base/library.html" class="external-link">library</a></span><span class="op">(</span><span class="st"><a href="https://github.com/openpharma/crmPack" class="external-link">"crmPack"</a></span><span class="op">)</span></span></code></pre></div>
<pre><code><span><span class="co">## Loading required package: ggplot2</span></span></code></pre>
<pre><code><span><span class="co">## Registered S3 method overwritten by 'crmPack':</span></span>
<span><span class="co">##   method       from  </span></span>
<span><span class="co">##   print.gtable gtable</span></span></code></pre>
<pre><code><span><span class="co">## Type crmPackHelp() to open help browser</span></span>
<span><span class="co">## Type crmPackExample() to open example</span></span></code></pre>
<blockquote>
<p>As indicated in the startup message, try <code><a href="../reference/crmPackHelp.html">crmPackHelp()</a></code>
and <code><a href="../reference/crmPackExample.html">crmPackExample()</a></code> to open the help page and the package
vignette.</p>
</blockquote>
<div class="section level3">
<h3 id="implementing-a-crm-trial">Implementing a CRM trial<a class="anchor" aria-label="anchor" href="#implementing-a-crm-trial"></a>
</h3>
<p>Suppose that 12 dose levels ranging from 25 to 300 mg in 25 mg
increments of a novel agent are available in addition to placebo,
defining our dose grid <span class="math inline">\(\mathcal{X} =
\{0.001,25, 50,\dotsc, 300\}\)</span>, with <span class="math inline">\(x_{1} = 0.001\)</span> mg representing placebo and
<span class="math inline">\(x_{2} = 25\)</span> being our starting dose.
Note that here we used a very small dose instead of zero for <span class="math inline">\(x_{1}\)</span>, since we consider here the
regression model @eqref(eq:LogisticLogNormal) with a log transformation
of the dose <span class="math inline">\(x\)</span> (with <span class="math inline">\(x^{*} = 100\)</span> chosen as reference
dose).</p>
<p><strong>Minimally informative prior</strong> Here we assume that
limited prior information is available on the dose-toxicity
relationship, and hence would like to use a minimally informative prior
<span class="citation">(Neuenschwander, Branson, and Gsponer
2008)</span> which can be easily obtained with the function
<code>MinimalInformative</code>. Since stochastic optimization is used
internally, setting of a seed is required for reproducibility.
Furthermore, it is recommended to specify a coarse dose grid across the
original dose range (excluding the placebo dose) to avoid long
computation time:</p>
<div class="sourceCode" id="cb6"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">coarseGrid</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="fl">25</span>, <span class="fl">50</span>, <span class="fl">100</span>, <span class="fl">200</span>, <span class="fl">300</span><span class="op">)</span></span>
<span><span class="va">model</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/MinimalInformative.html">MinimalInformative</a></span><span class="op">(</span></span>
<span>  dosegrid <span class="op">=</span> <span class="va">coarseGrid</span>, refDose <span class="op">=</span> <span class="fl">100</span>,</span>
<span>  logNormal <span class="op">=</span> <span class="cn">TRUE</span>, threshmin <span class="op">=</span> <span class="fl">0.1</span>,</span>
<span>  threshmax <span class="op">=</span> <span class="fl">0.2</span>, seed <span class="op">=</span> <span class="fl">432</span>,</span>
<span>  control <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span>max.time <span class="op">=</span> <span class="fl">30</span><span class="op">)</span></span>
<span><span class="op">)</span><span class="op">$</span><span class="va">model</span></span></code></pre></div>
<p>The resulting <code>model</code> (which is an object of class
<code>LogisticLogNormal</code>) has prior parameters</p>
<p><span class="math display">\[\mu = (0.0720313, 2)\]</span></p>
<p>and</p>
<p><span class="math display">\[\Sigma=
\left(\begin{smallmatrix}
   1.51 &amp; 0.18 \\
   0.18 &amp; 0.21
\end{smallmatrix}\right)\]</span> and will approximately have 5%
probability each for the DLT rate to exceed 10% (<code>threshmin</code>
argument) at the 25 mg dose and to be below 20% (<code>threshmax</code>)
at the 300 mg dose.</p>
<p><strong>Data object definition and visualization</strong> In this
simple case of a univariate dose <span class="math inline">\(x\)</span>
resulting in binary DLT observations <span class="math inline">\(y\)</span>, the <code>S4</code> class
<code>Data</code> can be used. Objects of this class can be created by
calling the accompanying initialization function of the same name (which
is a general convention in <code>crmPack</code>):</p>
<div class="sourceCode" id="cb7"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">PL</span> <span class="op">&lt;-</span> <span class="fl">0.001</span></span>
<span><span class="va">data</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/Data-class.html">Data</a></span><span class="op">(</span></span>
<span>  x <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="va">PL</span>, <span class="fl">25</span>, <span class="fl">25</span>, <span class="fl">25</span>, <span class="va">PL</span>, <span class="fl">50</span>, <span class="fl">50</span>, <span class="fl">50</span>, <span class="va">PL</span>, <span class="fl">100</span>, <span class="fl">100</span>, <span class="fl">100</span><span class="op">)</span>,</span>
<span>  y <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="fl">0</span>, <span class="fl">0</span>, <span class="fl">0</span>, <span class="fl">0</span>, <span class="fl">0</span>, <span class="fl">0</span>, <span class="fl">0</span>, <span class="fl">0</span>, <span class="fl">0</span>, <span class="fl">0</span>, <span class="fl">1</span>, <span class="fl">0</span><span class="op">)</span>,</span>
<span>  cohort <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="fl">1</span>, <span class="fl">1</span>, <span class="fl">1</span>, <span class="fl">1</span>, <span class="fl">2</span>, <span class="fl">2</span>, <span class="fl">2</span>, <span class="fl">2</span>, <span class="fl">3</span>, <span class="fl">3</span>, <span class="fl">3</span>, <span class="fl">3</span><span class="op">)</span>,</span>
<span>  doseGrid <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="va">PL</span>, <span class="fu"><a href="https://rdrr.io/r/base/seq.html" class="external-link">seq</a></span><span class="op">(</span><span class="fl">25</span>, <span class="fl">300</span>, <span class="fl">25</span><span class="op">)</span><span class="op">)</span>,</span>
<span>  ID <span class="op">=</span> <span class="fl">1</span><span class="op">:</span><span class="fl">12</span>,</span>
<span>  placebo <span class="op">=</span> <span class="cn">TRUE</span></span>
<span><span class="op">)</span></span></code></pre></div>
<p>The argument <code>x</code> takes the doses <span class="math inline">\(x_{1}=0.001, x_{2}=25, x_{3} = 50, x_{4} =
100\)</span> (note the repetition to match the outcome variables <span class="math inline">\(y_{j,k}\)</span>) where <code>doseGrid</code>
captures the set <span class="math inline">\({\cal X}\)</span> of all
possible doses, <code>y</code> takes the binary DLTs (here <span class="math inline">\(y_{3, 3} = 1\)</span> denotes the only DLT having
been observed in the 3rd patient in the 3rd cohort), while
<code>cohort</code> groups the patients together in cohorts (here <span class="math inline">\(N=3\)</span>). The option <code>placebo</code> is
used to specify that this is a placebo controlled study, with placebo
patients included in each cohort. The lowest dose <span class="math inline">\(x_{1}\)</span> is then interpreted internally as
the placebo dose. Patient IDs can be given optionally in the
<code>ID</code> argument. The data can then be visualized by simply
applying the <code>plot</code> function to the object, which also allows
to produce a blinded plot (hiding patient IDs and placebo/treatment
assignment) with the option <code>blind</code>, see Figure
@ref(fig:plot-data):</p>
<div class="sourceCode" id="cb8"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="https://rdrr.io/r/graphics/plot.default.html" class="external-link">plot</a></span><span class="op">(</span><span class="va">data</span><span class="op">)</span></span>
<span><span class="fu"><a href="https://rdrr.io/r/graphics/plot.default.html" class="external-link">plot</a></span><span class="op">(</span><span class="va">data</span>, blind <span class="op">=</span> <span class="cn">TRUE</span><span class="op">)</span></span></code></pre></div>
<div class="figure" style="text-align: center">
<img src="crmPack-jss-paper_files/figure-html/plot-data-1.png" alt="Open and blinded data plots" width=".35\linewidth"><img src="crmPack-jss-paper_files/figure-html/plot-data-2.png" alt="Open and blinded data plots" width=".35\linewidth"><p class="caption">
Open and blinded data plots
</p>
</div>
<p><strong>Sampling from the prior and posterior</strong> Now that we
have the model and the data in place, we can use MCMC sampling for
obtaining the posterior distribution of the model parameters <span class="math inline">\(\theta\)</span>, and hence the DLT rates <span class="math inline">\(Prob(Y=1 | x,\theta)\)</span>, at various doses
<span class="math inline">\(x\)</span>. The MCMC sampling can be
controlled with an object of class <code>McmcOptions</code>, which is
then provided to the <code>mcmc</code> function, together with the
<code>data</code> and the <code>model</code> objects:</p>
<div class="sourceCode" id="cb9"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">options</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/McmcOptions-class.html">McmcOptions</a></span><span class="op">(</span>burnin <span class="op">=</span> <span class="fl">1000</span>, step <span class="op">=</span> <span class="fl">2</span>, samples <span class="op">=</span> <span class="fl">10000</span><span class="op">)</span></span>
<span><span class="fu"><a href="https://rdrr.io/r/base/Random.html" class="external-link">set.seed</a></span><span class="op">(</span><span class="fl">94</span><span class="op">)</span></span>
<span><span class="va">samples</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/mcmc.html">mcmc</a></span><span class="op">(</span><span class="va">data</span>, <span class="va">model</span>, <span class="va">options</span><span class="op">)</span></span></code></pre></div>
<p>The posterior mean curve and 95% equi-tailed credible interval curves
for the DLT rates can be obtained by supplying the samples, model and
data to the generic <code>plot</code> function. Similarly we can also
produce a similar plot without any data, which is then giving the prior,
see Figure @ref(fig:plot-model-fit):</p>
<div class="sourceCode" id="cb10"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="https://rdrr.io/r/graphics/plot.default.html" class="external-link">plot</a></span><span class="op">(</span><span class="va">samples</span>, <span class="va">model</span>, <span class="va">data</span><span class="op">)</span> <span class="op">+</span> <span class="fu">ggtitle</span><span class="op">(</span><span class="st">"Posterior"</span><span class="op">)</span></span>
<span></span>
<span><span class="va">emptydata</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/Data-class.html">Data</a></span><span class="op">(</span>doseGrid <span class="op">=</span> <span class="va">data</span><span class="op">@</span><span class="va">doseGrid</span>, placebo <span class="op">=</span> <span class="cn">TRUE</span><span class="op">)</span></span>
<span><span class="va">priorsamples</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/mcmc.html">mcmc</a></span><span class="op">(</span><span class="va">emptydata</span>, <span class="va">model</span>, <span class="va">options</span><span class="op">)</span></span>
<span><span class="fu"><a href="https://rdrr.io/r/graphics/plot.default.html" class="external-link">plot</a></span><span class="op">(</span><span class="va">priorsamples</span>, <span class="va">model</span>, <span class="va">emptydata</span><span class="op">)</span> <span class="op">+</span> <span class="fu">ggtitle</span><span class="op">(</span><span class="st">"Prior"</span><span class="op">)</span></span></code></pre></div>
<div class="figure" style="text-align: center">
<img src="crmPack-jss-paper_files/figure-html/plot-model-fit-1.png" alt="Posterior and prior regression model fits" width=".35\linewidth"><img src="crmPack-jss-paper_files/figure-html/plot-model-fit-2.png" alt="Posterior and prior regression model fits" width=".35\linewidth"><p class="caption">
Posterior and prior regression model fits
</p>
</div>
<p>As illustrated here, the plots can be customized by using the
<code>ggplot2</code><span class="citation">(Wickham 2009)</span>
functionality. We can see that while the posterior mean estimate (left
panel, continuous line) is only slightly steeper than the prior mean
estimate curve (right panel, continuous line), the posterior uncertainty
is reduced due to the data (smaller credible intervals, dashed
lines).</p>
<p><strong>Decision making for the next dose</strong> To determine which
dose to administer to the next (cohort of) patients we begin by
specifying the maximum increments function <span class="math inline">\(\tau\)</span>. In the example below a maximum
increase of 100% for doses below 100 mg, 50% for doses in the range from
100 mg to 200 mg, and 33% for doses equal or above 200 mg is specified
using the class <code>IncrementsRelative</code>:</p>
<div class="sourceCode" id="cb11"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">myIncrements</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/IncrementsRelative-class.html">IncrementsRelative</a></span><span class="op">(</span></span>
<span>  intervals <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="fl">0</span>, <span class="fl">100</span>, <span class="fl">200</span><span class="op">)</span>,</span>
<span>  increments <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="fl">1</span>, <span class="fl">0.5</span>, <span class="fl">0.33</span><span class="op">)</span></span>
<span><span class="op">)</span></span></code></pre></div>
<p>This specific rule <span class="math inline">\(\tau\)</span> can then
be evaluated on the current dataset <span class="math inline">\({\cal
D}_{N}\)</span> by the <code>maxDose</code> function to obtain the
maximum next dose <span class="math inline">\(t_{N+1} = \tau({\cal
D}_{N})\)</span>:</p>
<div class="sourceCode" id="cb12"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="op">(</span><span class="va">nextMaxDose</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/maxDose.html">maxDose</a></span><span class="op">(</span><span class="va">myIncrements</span>, <span class="va">data</span><span class="op">)</span><span class="op">)</span></span></code></pre></div>
<pre><code><span><span class="co">## [1] 150</span></span></code></pre>
<p>We then define the function <span class="math inline">\(\nu\)</span>
for selecting a dose for the next cohort. In this case we would like to
select the dose which maximizes the probability of the DLT rate being in
the target toxicity range from 20% to 35%, but with the probability of
overdosing not exceeding 25% <span class="citation">(Neuenschwander,
Branson, and Gsponer 2008)</span>, using the <code>NextBestNCRM</code>
class:</p>
<div class="sourceCode" id="cb14"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">myNextBest</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/NextBestNCRM-class.html">NextBestNCRM</a></span><span class="op">(</span></span>
<span>  target <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="fl">0.2</span>, <span class="fl">0.35</span><span class="op">)</span>, overdose <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="fl">0.35</span>, <span class="fl">1</span><span class="op">)</span>,</span>
<span>  max_overdose_prob <span class="op">=</span> <span class="fl">0.25</span></span>
<span><span class="op">)</span></span></code></pre></div>
<p>This rule can then be evaluated with the function
<code>NextBest</code> to obtain the next dose <span class="math inline">\(x_{N+1}=\nu({\cal D}_{N}, t_{N+1})\)</span>:</p>
<div class="sourceCode" id="cb15"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">nextDoseRes</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/nextBest.html">nextBest</a></span><span class="op">(</span><span class="va">myNextBest</span>, <span class="va">nextMaxDose</span>, <span class="va">samples</span>, <span class="va">model</span>, <span class="va">data</span><span class="op">)</span></span>
<span><span class="op">(</span><span class="va">nextDoseVal</span> <span class="op">&lt;-</span> <span class="va">nextDoseRes</span><span class="op">$</span><span class="va">value</span><span class="op">)</span></span></code></pre></div>
<pre><code><span><span class="co">## [1] 100</span></span></code></pre>
<p>The returned list also contains an accompanying plot
(<code>nextDoseRes$plot</code>), see Figure @ref(fig:nextBest-ncrm).</p>
<div class="figure" style="text-align: center">
<img src="crmPack-jss-paper_files/figure-html/nextBest-ncrm-1.png" alt="Dose recommendation plot from NCRM design" width=".5\linewidth"><p class="caption">
Dose recommendation plot from NCRM design
</p>
</div>
<p><strong>Adaptive stopping of the trial</strong> We would like to stop
the dose escalation adaptively if the maximum sample size of <span class="math inline">\(n=30\)</span> patients has been reached already,
or if we have sufficient precision for the MTD estimate. We can specify
the latter condition as follows: The probability that the next dose
<span class="math inline">\(x_{N+1}\)</span> is in the target toxicity
range is above 50%, and at least 9 patients were already dosed within
+/- 20% range of <span class="math inline">\(x_{N+1}\)</span>. The
corresponding <code>Stopping</code> class object is constructed by
combining the atomic rules with logical operators as follows:</p>
<div class="sourceCode" id="cb17"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">myStopping1</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/StoppingMinPatients-class.html">StoppingMinPatients</a></span><span class="op">(</span>nPatients <span class="op">=</span> <span class="fl">30</span><span class="op">)</span></span>
<span><span class="va">myStopping2</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/StoppingTargetProb-class.html">StoppingTargetProb</a></span><span class="op">(</span>target <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="fl">0.2</span>, <span class="fl">0.35</span><span class="op">)</span>, prob <span class="op">=</span> <span class="fl">0.5</span><span class="op">)</span></span>
<span><span class="va">myStopping3</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/StoppingPatientsNearDose-class.html">StoppingPatientsNearDose</a></span><span class="op">(</span>nPatients <span class="op">=</span> <span class="fl">9</span>, percentage <span class="op">=</span> <span class="fl">20</span><span class="op">)</span></span>
<span><span class="va">myStopping</span> <span class="op">&lt;-</span> <span class="va">myStopping1</span> <span class="op">|</span> <span class="op">(</span><span class="va">myStopping2</span> <span class="op">&amp;</span> <span class="va">myStopping3</span><span class="op">)</span></span></code></pre></div>
<p>Again, this specific rule can be evaluated by a function, here called
<code>stopTrial</code>, for a specific situation:</p>
<div class="sourceCode" id="cb18"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/stopTrial.html">stopTrial</a></span><span class="op">(</span><span class="va">myStopping</span>, <span class="va">nextDoseVal</span>, <span class="va">samples</span>, <span class="va">model</span>, <span class="va">data</span><span class="op">)</span></span></code></pre></div>
<pre><code><span><span class="co">## [1] FALSE</span></span>
<span><span class="co">## attr(,"message")</span></span>
<span><span class="co">## attr(,"message")[[1]]</span></span>
<span><span class="co">## [1] "Number of patients is 12 and thus below the prespecified minimum number 30"</span></span>
<span><span class="co">## </span></span>
<span><span class="co">## attr(,"message")[[2]]</span></span>
<span><span class="co">## attr(,"message")[[2]][[1]]</span></span>
<span><span class="co">## [1] "Probability for target toxicity is 33 % for dose 100 and thus below the required 50 %"</span></span>
<span><span class="co">## </span></span>
<span><span class="co">## attr(,"message")[[2]][[2]]</span></span>
<span><span class="co">## [1] "3 patients lie within 20% of the next best dose 100. This is below the required 9 patients"</span></span>
<span><span class="co">## </span></span>
<span><span class="co">## </span></span>
<span><span class="co">## attr(,"individual")</span></span>
<span><span class="co">## attr(,"individual")[[1]]</span></span>
<span><span class="co">## [1] FALSE</span></span>
<span><span class="co">## attr(,"message")</span></span>
<span><span class="co">## [1] "Number of patients is 12 and thus below the prespecified minimum number 30"</span></span>
<span><span class="co">## attr(,"report_label")</span></span>
<span><span class="co">## [1] "≥ 30 patients dosed"</span></span>
<span><span class="co">## </span></span>
<span><span class="co">## attr(,"individual")[[2]]</span></span>
<span><span class="co">## [1] FALSE</span></span>
<span><span class="co">## attr(,"message")</span></span>
<span><span class="co">## attr(,"message")[[1]]</span></span>
<span><span class="co">## [1] "Probability for target toxicity is 33 % for dose 100 and thus below the required 50 %"</span></span>
<span><span class="co">## </span></span>
<span><span class="co">## attr(,"message")[[2]]</span></span>
<span><span class="co">## [1] "3 patients lie within 20% of the next best dose 100. This is below the required 9 patients"</span></span>
<span><span class="co">## </span></span>
<span><span class="co">## attr(,"individual")</span></span>
<span><span class="co">## attr(,"individual")[[1]]</span></span>
<span><span class="co">## [1] FALSE</span></span>
<span><span class="co">## attr(,"message")</span></span>
<span><span class="co">## [1] "Probability for target toxicity is 33 % for dose 100 and thus below the required 50 %"</span></span>
<span><span class="co">## attr(,"report_label")</span></span>
<span><span class="co">## [1] "P(0.2 ≤ prob(DLE | NBD) ≤ 0.35) ≥ 0.5"</span></span>
<span><span class="co">## </span></span>
<span><span class="co">## attr(,"individual")[[2]]</span></span>
<span><span class="co">## [1] FALSE</span></span>
<span><span class="co">## attr(,"message")</span></span>
<span><span class="co">## [1] "3 patients lie within 20% of the next best dose 100. This is below the required 9 patients"</span></span>
<span><span class="co">## attr(,"report_label")</span></span>
<span><span class="co">## [1] "≥ 9 patients dosed in 20 % dose range around NBD"</span></span>
<span><span class="co">## </span></span>
<span><span class="co">## attr(,"report_label")</span></span>
<span><span class="co">## [1] NA</span></span>
<span><span class="co">## </span></span>
<span><span class="co">## attr(,"report_label")</span></span>
<span><span class="co">## [1] NA</span></span></code></pre>
<p>The result <code>FALSE</code> means that we cannot yet stop the
trial, with the attribute <code>message</code> giving the results from
the atomic stopping rules.</p>
<p><strong>Examine the dose escalation design</strong> In the last topic
of this section, we want to show how to assess the performance of a
given CRM design. We first need to specify our design by creating an
object of class <code>Design</code>. It contains our model, our rules
for dose escalation (<code>Increments</code>, <code>NextBest</code>,
<code>Stopping</code> and <code>CohortSize</code>), the dose grid (in
the example below through the object <code>emptydata</code>) and our
starting dose (see also Figure @ref(fig:schematic). In this case we will
use a fixed cohort size of 3 patients on active and 1 patient on placebo
(``3+1’’) throughout the study:</p>
<div class="sourceCode" id="cb20"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">mySize</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/CohortSizeConst-class.html">CohortSizeConst</a></span><span class="op">(</span><span class="fl">3</span><span class="op">)</span></span>
<span><span class="va">mySizePL</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/CohortSizeConst-class.html">CohortSizeConst</a></span><span class="op">(</span><span class="fl">1</span><span class="op">)</span></span>
<span></span>
<span><span class="va">design</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/Design-class.html">Design</a></span><span class="op">(</span></span>
<span>  model <span class="op">=</span> <span class="va">model</span>, nextBest <span class="op">=</span> <span class="va">myNextBest</span>,</span>
<span>  stopping <span class="op">=</span> <span class="va">myStopping</span>, increments <span class="op">=</span> <span class="va">myIncrements</span>,</span>
<span>  cohort_size <span class="op">=</span> <span class="va">mySize</span>, pl_cohort_size <span class="op">=</span> <span class="va">mySizePL</span>,</span>
<span>  data <span class="op">=</span> <span class="va">emptydata</span>, startingDose <span class="op">=</span> <span class="fl">25</span></span>
<span><span class="op">)</span></span></code></pre></div>
<p>We can then start by looking at the single trial operating
characteristics of the dose escalation design with the function
<code>examine</code>, which generates a data frame showing the beginning
of several hypothetical trial courses under the design. Assuming no DLTs
have been seen until a certain dose, then the consequences of different
number of DLTs being observed at this dose are shown. For example, if we
observe 3 DLTs at the starting dose of 25 mg, we would need to stop the
trial, while we would enroll another cohort at the same dose level in
case of 2 DLTs. In the last rows of the output we see that if no DLTs
were observed before the 250 mg cohort, the maximum considered dose of
300 mg dose can be reached in the next cohort if also no DLTs are
observed at 250 mg. If 1, 2 or 3 DLTs are observed, the next dose is
recommended as 225, 175 and 150 mg, respectively.</p>
<div class="sourceCode" id="cb21"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="https://rdrr.io/r/base/Random.html" class="external-link">set.seed</a></span><span class="op">(</span><span class="fl">23</span><span class="op">)</span></span>
<span><span class="fu"><a href="../reference/examine.html">examine</a></span><span class="op">(</span><span class="va">design</span>, mcmcOptions <span class="op">=</span> <span class="va">options</span><span class="op">)</span></span></code></pre></div>
<pre><code><span><span class="co">##    dose DLTs nextDose  stop increment</span></span>
<span><span class="co">## 1    25    0       50 FALSE       100</span></span>
<span><span class="co">## 2    25    1       50 FALSE       100</span></span>
<span><span class="co">## 3    25    2       25 FALSE         0</span></span>
<span><span class="co">## 4    25    3       NA FALSE        NA</span></span>
<span><span class="co">## 5    50    0      100 FALSE       100</span></span>
<span><span class="co">## 6    50    1       75 FALSE        50</span></span>
<span><span class="co">## 7    50    2       50 FALSE         0</span></span>
<span><span class="co">## 8    50    3       25 FALSE       -50</span></span>
<span><span class="co">## 9   100    0      125 FALSE        25</span></span>
<span><span class="co">## 10  100    1      100 FALSE         0</span></span>
<span><span class="co">## 11  100    2       75 FALSE       -25</span></span>
<span><span class="co">## 12  100    3       50 FALSE       -50</span></span>
<span><span class="co">## 13  125    0      175 FALSE        40</span></span>
<span><span class="co">## 14  125    1      125 FALSE         0</span></span>
<span><span class="co">## 15  125    2      100 FALSE       -20</span></span>
<span><span class="co">## 16  125    3       75 FALSE       -40</span></span>
<span><span class="co">## 17  175    0      250 FALSE        43</span></span>
<span><span class="co">## 18  175    1      150 FALSE       -14</span></span>
<span><span class="co">## 19  175    2      125 FALSE       -29</span></span>
<span><span class="co">## 20  175    3      100 FALSE       -43</span></span>
<span><span class="co">## 21  250    0      300 FALSE        20</span></span>
<span><span class="co">## 22  250    1      225 FALSE       -10</span></span>
<span><span class="co">## 23  250    2      175 FALSE       -30</span></span>
<span><span class="co">## 24  250    3      150 FALSE       -40</span></span></code></pre>
<p><strong>Simulating operating characteristics</strong> For the many
trials operating characteristics, we first have to define true
scenarios, from which the data should arise. In this case, this only
requires a function that computes the probability of DLT given a dose.
As an example we use here the function contained in the slot
<code>prob</code> of the object <code>model</code>: %, for which the
dose-toxicity curve is shown below.</p>
<div class="sourceCode" id="cb23"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">myTruth</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/probFunction.html">probFunction</a></span><span class="op">(</span><span class="va">model</span>, alpha0 <span class="op">=</span> <span class="fl">4.5</span>, alpha1 <span class="op">=</span> <span class="fl">8</span><span class="op">)</span></span></code></pre></div>
<p>Note that any possible R-function returning a vector of probabilities
upon input of the dose vector can be used. In particular, it is
trivially possible to directly specify the probability of DLT for each
dose in order to examine operating characteristics not based on any
statistical model. For example, assume 5 doses 1–5 with probabilities of
DLT of 0.01, 0.02, 0.04, 0.06, 0.09, then the following code could be
used:</p>
<div class="sourceCode" id="cb24"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">doseProbMatrix</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/base/cbind.html" class="external-link">cbind</a></span><span class="op">(</span><span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="fl">1</span>, <span class="fl">2</span>, <span class="fl">3</span>, <span class="fl">4</span>, <span class="fl">5</span><span class="op">)</span>, <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="fl">0.01</span>, <span class="fl">0.02</span>, <span class="fl">0.04</span>, <span class="fl">0.06</span>, <span class="fl">0.09</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="va">myTruthMatrix</span> <span class="op">&lt;-</span></span>
<span>  <span class="kw">function</span><span class="op">(</span><span class="va">dose</span><span class="op">)</span> <span class="op">{</span></span>
<span>    <span class="va">doseProbMatrix</span><span class="op">[</span><span class="fu"><a href="https://rdrr.io/r/base/match.html" class="external-link">match</a></span><span class="op">(</span><span class="va">dose</span>, <span class="va">doseProbMatrix</span><span class="op">[</span>, <span class="fl">1</span><span class="op">]</span><span class="op">)</span>, <span class="fl">2</span><span class="op">]</span></span>
<span>  <span class="op">}</span></span></code></pre></div>
<p>Now we can proceed to the simulations using the function
<code>simulate</code>:</p>
<div class="sourceCode" id="cb25"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">mySimsTime</span> <span class="op">&lt;-</span></span>
<span>  <span class="fu"><a href="https://rdrr.io/r/base/system.time.html" class="external-link">system.time</a></span><span class="op">(</span><span class="va">mySims</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/stats/simulate.html" class="external-link">simulate</a></span><span class="op">(</span><span class="va">design</span>,</span>
<span>    truth <span class="op">=</span> <span class="va">myTruth</span>, nsim <span class="op">=</span> <span class="fl">100</span>,</span>
<span>    seed <span class="op">=</span> <span class="fl">819</span>, mcmcOptions <span class="op">=</span> <span class="va">options</span>,</span>
<span>    parallel <span class="op">=</span> <span class="cn">FALSE</span></span>
<span>  <span class="op">)</span><span class="op">)</span><span class="op">[</span><span class="fl">3</span><span class="op">]</span></span></code></pre></div>
<p>The number of simulated trials depends on the required accuracy of
the results. The argument <code>parallel</code> can be set to
<code>TRUE</code> if one wishes to run the iterations in parallel on all
processors of the computer, which can yield a meaningful speedup. Here
we needed 121 seconds for 100 simulated trials on an Intel Core i5-6300U
CPU with 2.4 GHz.</p>
<p>The result is an object of class <code>Simulations</code> containing
multiple slots, with e.g., the <code>data</code> slot containing the
list of simulated trials. The slots <code>doses</code> and
<code>stopReasons</code> contain information about the final MTD and the
stopping reason for each trial. We can e.g., investigate the number of
patients and the MTD at the end of the third simulated trial:</p>
<div class="sourceCode" id="cb26"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">mySims</span><span class="op">@</span><span class="va">data</span><span class="op">[[</span><span class="fl">3</span><span class="op">]</span><span class="op">]</span><span class="op">@</span><span class="va">nObs</span></span></code></pre></div>
<pre><code><span><span class="co">## [1] 32</span></span></code></pre>
<div class="sourceCode" id="cb28"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">mySims</span><span class="op">@</span><span class="va">doses</span><span class="op">[</span><span class="fl">3</span><span class="op">]</span></span></code></pre></div>
<pre><code><span><span class="co">## [1] 25</span></span></code></pre>
Furthermore, we can plot the <code>Simulations</code> object by calling
the <code>plot</code> method on it, see Figure @ref(fig:sim-plot). You
can select the plots by changing the <code>type</code> argument of
<code>plot</code>, which by default is
<code>type = c("trajectory", "dosesTried")</code>.
<div class="figure" style="text-align: center">
<img src="crmPack-jss-paper_files/figure-html/sim-plot-1.png" alt="Simulation plot" width=".5\linewidth"><p class="caption">
Simulation plot
</p>
</div>
<p>Second, we can summarize the simulation results, and obtain a textual
description of the results:</p>
<div class="sourceCode" id="cb30"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">simSum</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/base/summary.html" class="external-link">summary</a></span><span class="op">(</span><span class="va">mySims</span>, truth <span class="op">=</span> <span class="va">myTruth</span><span class="op">)</span></span>
<span><span class="va">simSum</span></span></code></pre></div>
<pre><code><span><span class="co">## Summary of 100 simulations</span></span>
<span><span class="co">## </span></span>
<span><span class="co">## Target toxicity interval was 20, 35 %</span></span>
<span><span class="co">## Target dose interval corresponding to this was 47.9, 52.7 </span></span>
<span><span class="co">## Intervals are corresponding to 10 and 90 % quantiles</span></span>
<span><span class="co">## </span></span>
<span><span class="co">## Number of patients on placebo : mean 7 (6, 8) </span></span>
<span><span class="co">## Number of patients on active : mean 22 (18, 24) </span></span>
<span><span class="co">## Number of patients overall : mean 30 (24, 32) </span></span>
<span><span class="co">## Number of patients treated above target tox interval : mean 3 (0, 3) </span></span>
<span><span class="co">## Proportions of DLTs in the trials for patients on placebo : mean 0 % (0 %, 0 %) </span></span>
<span><span class="co">## Proportions of DLTs in the trials for patients on active : mean 28 % (21 %, 34 %) </span></span>
<span><span class="co">## Mean toxicity risks for the patients on active : mean 27 % (18 %, 33 %) </span></span>
<span><span class="co">## Doses selected as MTD : mean 46.8 (25, 50) </span></span>
<span><span class="co">## True toxicity at doses selected : mean 23 % (0 %, 26 %) </span></span>
<span><span class="co">## Proportion of trials selecting target MTD: 87 %</span></span>
<span><span class="co">## Dose most often selected as MTD: 50 </span></span>
<span><span class="co">## Observed toxicity rate at dose most often selected: 27 %</span></span>
<span><span class="co">## Fitted toxicity rate at dose most often selected : mean 23 % (17 %, 30 %) </span></span>
<span><span class="co">## Stop reason triggered:</span></span>
<span><span class="co">##  ≥ 30 patients dosed :  62 %</span></span>
<span><span class="co">##  P(0.2 ≤ prob(DLE | NBD) ≤ 0.35) ≥ 0.5 :  50 %</span></span>
<span><span class="co">##  ≥ 9 patients dosed in 20 % dose range around NBD :  98 %</span></span></code></pre>
A plot of the summary results can also be produced, see Figure
@ref(fig:sim-summary-plot).
<div class="figure" style="text-align: center">
<img src="crmPack-jss-paper_files/figure-html/sim-summary-plot-1.png" alt="Simulation summary plot" width=".6\linewidth"><p class="caption">
Simulation summary plot
</p>
</div>
</div>
<div class="section level3">
<h3 id="dose-escalation-with-safety-and-efficacy">Dose escalation with safety and efficacy<a class="anchor" aria-label="anchor" href="#dose-escalation-with-safety-and-efficacy"></a>
</h3>
<p>In this section, dose escalation designs incorporating both safety
(as binary DLT) and efficacy endpoints (continuous response) will be
introduced. Dual endpoint datasets are implemented with the
<code>DualData</code> class, where here we illustrate the addition of
the efficacy data <code>w</code> to the previous dataset:</p>
<div class="sourceCode" id="cb32"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">data2</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/DataDual-class.html">DataDual</a></span><span class="op">(</span></span>
<span>  x <span class="op">=</span> <span class="va">data</span><span class="op">@</span><span class="va">x</span>, y <span class="op">=</span> <span class="va">data</span><span class="op">@</span><span class="va">y</span>, placebo <span class="op">=</span> <span class="cn">TRUE</span>,</span>
<span>  w <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span></span>
<span>    <span class="fl">0.02</span>, <span class="fl">0.42</span>, <span class="fl">0.59</span>, <span class="fl">0.45</span>, <span class="fl">0.03</span>, <span class="fl">0.7</span>, <span class="fl">0.6</span>, <span class="fl">0.52</span>,</span>
<span>    <span class="fl">0.01</span>, <span class="fl">0.71</span>, <span class="fl">0.54</span>, <span class="fl">0.45</span></span>
<span>  <span class="op">)</span>, cohort <span class="op">=</span> <span class="va">data</span><span class="op">@</span><span class="va">cohort</span>,</span>
<span>  doseGrid <span class="op">=</span> <span class="va">data</span><span class="op">@</span><span class="va">doseGrid</span>, ID <span class="op">=</span> <span class="va">data</span><span class="op">@</span><span class="va">ID</span></span>
<span><span class="op">)</span></span></code></pre></div>
<p>The endpoints can be modelled jointly or separately. For joint
modelling derived from <span class="citation">(Bekele and Shen
2005)</span>, please see the package vignette and the
<code>DualEndpoint</code> class. In the following section we will
describe separate modelling, as proposed in <span class="citation">(Yeung et al. 2015)</span>. We will show how the dual
endpoint design can help to estimate an optimal dose level which
represents the best trade-off between safety and efficacy.</p>
<p><strong>Methodology</strong> Briefly introducing the methodology in
current notation, assume that the dose grid <span class="math inline">\(\cal{X}\)</span> contains <span class="math inline">\(k\)</span> dose levels, and the logistic
regression model @<span class="math inline">\(\eqref{eq:LogisticLogNormal}\)</span> with <span class="math inline">\(x^{*}=1\)</span> is used for the safety endpoint
<span class="math inline">\(y\)</span>. For the continuous efficacy
endpoint <span class="math inline">\(w\)</span>, a linear log-log model
can be used, conditional on <span class="math inline">\(y=0\)</span> (no
DLT): <span class="math display">\[\begin{equation}\label{eq:loglog}
E(w(x)) = \gamma + \delta \log\{\log(x + c)\}
\end{equation}\]</span> such that <span class="math inline">\(w(x) \sim
N(E(w(x)), \sigma^2)\)</span> with <span class="math inline">\(c \geq
0\)</span> as a constant. Usually the default value <span class="math inline">\(c=0\)</span> can be used, but in our case we
choose <span class="math inline">\(c=2\)</span> to allow for the placebo
dose <span class="math inline">\(x=0.001\)</span> which is close to
0.</p>
<p>For both the safety and efficacy models, the prior will be expressed
in form of imaginary pseudo data see <span class="citation">(Yeung et
al. 2015)</span> for details. Prior and posterior modal estimates of the
model parameters can then be obtained as the maximum likelihood
estimates from the data set combining pseudo data with observed data
<span class="citation">(Whitehead 2006)</span>. The variance <span class="math inline">\(\sigma^{2}\)</span> can be fixed or assigned an
inverse gamma prior distribution.</p>
<p><strong>Model classes</strong> The <code>ModelPseudo</code> class
contains all model classes where the priors are specified in terms of
pseudo data, with subclasses for safety (<code>ModelTox</code>) and
efficacy (<code>ModelEff</code>).</p>
<p>Coming back to our example study, the pseudo data for the safety
prior assumes that 3 subjects each are treated at the lowest (25 mg) and
the highest (300 mg) dose level, with 1.05 and 1.8 DLTs being observed
at these two dose levels, respectively. This corresponds to prior means
of 0.35 and 0.6 for the DLT probabilities. We implement model @<span class="math inline">\(\eqref{eq:LogisticLogNormal}\)</span> with this
pseudo data prior as follows:</p>
<div class="sourceCode" id="cb33"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">DLTmodel</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/LogisticIndepBeta-class.html">LogisticIndepBeta</a></span><span class="op">(</span></span>
<span>  binDLE <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="fl">1.05</span>, <span class="fl">1.8</span><span class="op">)</span>, DLEweights <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="fl">3</span>, <span class="fl">3</span><span class="op">)</span>,</span>
<span>  DLEdose <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="fl">25</span>, <span class="fl">300</span><span class="op">)</span>, data <span class="op">=</span> <span class="va">emptydata</span></span>
<span><span class="op">)</span></span></code></pre></div>
<p>The efficacy model can similarly be specified as</p>
<div class="sourceCode" id="cb34"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">emptydata2</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/DataDual-class.html">DataDual</a></span><span class="op">(</span>doseGrid <span class="op">=</span> <span class="va">emptydata</span><span class="op">@</span><span class="va">doseGrid</span>, placebo <span class="op">=</span> <span class="cn">TRUE</span><span class="op">)</span></span>
<span><span class="va">Effmodel</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/Effloglog-class.html">Effloglog</a></span><span class="op">(</span></span>
<span>  eff <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="fl">1.223</span>, <span class="fl">2.513</span><span class="op">)</span>, eff_dose <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="fl">25</span>, <span class="fl">300</span><span class="op">)</span>,</span>
<span>  nu <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span>a <span class="op">=</span> <span class="fl">1</span>, b <span class="op">=</span> <span class="fl">0.025</span><span class="op">)</span>, data <span class="op">=</span> <span class="va">emptydata2</span>, c <span class="op">=</span> <span class="fl">2</span></span>
<span><span class="op">)</span></span></code></pre></div>
<p>Here the argument <code>Eff</code> takes the vector of pseudo
efficacy responses at the two fixed dose levels, assuming one subject is
treated at each of these dose levels. The argument <code>nu</code>
specifies a Gamma prior distribution with shape 1 and rate 0.025 for the
precision parameter of the pseudo efficacy responses.</p>
<p><strong>Decision making for the next dose</strong> A gain function is
used to quantify the trade-off between efficacy and safety, and the next
dose should maximize the estimated gain modulo safety constraints. Here
we will define the gain as the expected efficacy response, with the
convention that a DLT will automatically lead to a zero efficacy
response: <span class="math display">\[\begin{equation}
\label{eq:gainfunction}
G(x)=Prob(Y=0 | x, \theta)E(w(x))
\end{equation}\]</span> Note that the gain function depends on the
safety parameter vector <span class="math inline">\(\theta\)</span> and
the efficacy parameters <span class="math inline">\(\gamma\)</span> and
<span class="math inline">\(\delta\)</span>, which will be estimated by
their posterior modal estimates using the <code>update</code>
method:</p>
<div class="sourceCode" id="cb35"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">newDLTmodel</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/stats/update.html" class="external-link">update</a></span><span class="op">(</span>object <span class="op">=</span> <span class="va">DLTmodel</span>, data <span class="op">=</span> <span class="va">data2</span><span class="op">)</span></span>
<span><span class="va">newEffmodel</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/stats/update.html" class="external-link">update</a></span><span class="op">(</span>object <span class="op">=</span> <span class="va">Effmodel</span>, data <span class="op">=</span> <span class="va">data2</span><span class="op">)</span></span></code></pre></div>
<p>With <code>crmPack</code> we can implement the next best dose
recommendation based on maximizing the gain function as follows:</p>
<div class="sourceCode" id="cb36"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">GainNextBest</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/NextBestMaxGain-class.html">NextBestMaxGain</a></span><span class="op">(</span></span>
<span>  prob_target_drt <span class="op">=</span> <span class="fl">0.35</span>,</span>
<span>  prob_target_eot <span class="op">=</span> <span class="fl">0.3</span></span>
<span><span class="op">)</span></span></code></pre></div>
<p>where <code>prob_target_drt</code> specifies the maximum estimated
DLT rate tolerated during the study and <code>prob_target_eot</code> the
maximum estimated DLT rate tolerated at the end of the study. As in <a href="#implementing-a-crm-trial">Implementing a CRM trial</a> this rule
<span class="math inline">\(\nu\)</span> can be evaluated using
<code>NextBest</code> to obtain <span class="math inline">\(x_{N+1}\)</span>, after evaluating the maximum
increments rule <span class="math inline">\(\tau\)</span> using
<code>maxDose</code> to obtain <span class="math inline">\(t_{N+1}\)</span>:</p>
<div class="sourceCode" id="cb37"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="op">(</span><span class="va">nextMaxDose</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/maxDose.html">maxDose</a></span><span class="op">(</span><span class="va">myIncrements</span>, <span class="va">data2</span><span class="op">)</span><span class="op">)</span></span></code></pre></div>
<pre><code><span><span class="co">## [1] 150</span></span></code></pre>
<div class="sourceCode" id="cb39"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">doseRecGain</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/nextBest.html">nextBest</a></span><span class="op">(</span><span class="va">GainNextBest</span>,</span>
<span>  doselimit <span class="op">=</span> <span class="va">nextMaxDose</span>,</span>
<span>  model <span class="op">=</span> <span class="va">newDLTmodel</span>, model_eff <span class="op">=</span> <span class="va">newEffmodel</span>,</span>
<span>  data <span class="op">=</span> <span class="va">data2</span></span>
<span><span class="op">)</span></span>
<span><span class="op">(</span><span class="va">nextDoseVal</span> <span class="op">&lt;-</span> <span class="va">doseRecGain</span><span class="op">$</span><span class="va">next_dose</span><span class="op">)</span></span></code></pre></div>
<pre><code><span><span class="co">## [1] 25</span></span></code></pre>
<p>The plot for the next dose allocation is contained in
<code>doseRecGain$plot</code> and shown in Figure
@ref(fig:doseRecommendation). \begin{figure}
<img src="crmPack-jss-paper_files/figure-html/doseRecommendation-1.png" width=".6\linewidth" style="display: block; margin: auto;"></p>
<p>Dose recommendation plot from dual endpoint design. The red, blue and
green curves correspond to the (posterior modal) estimated curves for
safety, efficacy and gain, respectively. The vertical red line in the
plot shows the maximum possible dose <span class="math inline">\(t_{N+1}
= 150\)</span> mg and the vertical violet line shows the next dose <span class="math inline">\(x_{N+1} = 25\)</span> mg. The circle, square and
triangle symbols mark the estimated doses with target toxicity (100 mg
for 35% DLT probability during the trial and 75 mg for 30% DLT
probability at the end of trial) and the estimated dose with maximum
gain, 25 mg. The numbers can be obtained from the
<code>doseRecGain</code> list.</p>
<p><strong>Stopping rules</strong> In addition to the simple stopping
rule based on the maximum number of patients in our trial, we can use
another one relating to the precision of the dose with optimum gain:</p>
<div class="sourceCode" id="cb41"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">myStopping4</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/StoppingMaxGainCIRatio-class.html">StoppingMaxGainCIRatio</a></span><span class="op">(</span></span>
<span>  target_ratio <span class="op">=</span> <span class="fl">5</span>,</span>
<span>  prob_target <span class="op">=</span> <span class="va">GainNextBest</span><span class="op">@</span><span class="va">prob_target_eot</span></span>
<span><span class="op">)</span></span>
<span><span class="va">myStoppingDual</span> <span class="op">&lt;-</span> <span class="va">myStopping1</span> <span class="op">|</span> <span class="va">myStopping4</span></span></code></pre></div>
<p>This stops the trial when 30 patients are reached, or when the ratio
of the upper and lower confidence interval bounds around the dose
recommendation is less than 5.</p>
<p><strong>Simulations</strong> To simulate the operating
characteristics, first a design has to be built:</p>
<div class="sourceCode" id="cb42"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">design2</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/DualResponsesDesign-class.html">DualResponsesDesign</a></span><span class="op">(</span></span>
<span>  nextBest <span class="op">=</span> <span class="va">GainNextBest</span>, model <span class="op">=</span> <span class="va">DLTmodel</span>,</span>
<span>  eff_model <span class="op">=</span> <span class="va">Effmodel</span>, data <span class="op">=</span> <span class="va">emptydata2</span>,</span>
<span>  stopping <span class="op">=</span> <span class="va">myStoppingDual</span>,</span>
<span>  increments <span class="op">=</span> <span class="va">myIncrements</span>,</span>
<span>  cohort_size <span class="op">=</span> <span class="va">mySize</span>, startingDose <span class="op">=</span> <span class="fl">25</span></span>
<span><span class="op">)</span></span></code></pre></div>
<p>Note that an additional slot for the efficacy model is included in
this design class. We can then specify the scenario for the simulation,
by defining the true DLT and efficacy curves that we will be using:</p>
<div class="sourceCode" id="cb43"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">myTruthDLT</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/probFunction.html">probFunction</a></span><span class="op">(</span><span class="va">DLTmodel</span>, phi1 <span class="op">=</span> <span class="op">-</span><span class="fl">53</span>, phi2 <span class="op">=</span> <span class="fl">10</span><span class="op">)</span></span>
<span><span class="va">myTruthEff</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/efficacyFunction.html">efficacyFunction</a></span><span class="op">(</span><span class="va">Effmodel</span>, theta1 <span class="op">=</span> <span class="op">-</span><span class="fl">4.8</span>, theta2 <span class="op">=</span> <span class="fl">3.7</span><span class="op">)</span></span>
<span><span class="va">myTruthGain</span> <span class="op">&lt;-</span> <span class="kw">function</span><span class="op">(</span><span class="va">dose</span><span class="op">)</span> <span class="op">{</span></span>
<span>  <span class="fu">myTruthEff</span><span class="op">(</span><span class="va">dose</span><span class="op">)</span> <span class="op">*</span> <span class="op">(</span><span class="fl">1</span> <span class="op">-</span> <span class="fu">myTruthDLT</span><span class="op">(</span><span class="va">dose</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="op">}</span></span></code></pre></div>
<p>Please note that the parameter names <code>phi1</code>,
<code>phi2</code>, <code>theta1</code> and <code>theta2</code>
correspond to <span class="math inline">\(\alpha_0, \alpha_1,
\gamma\)</span> and <span class="math inline">\(\delta\)</span>,
respectively. Simulations are again produced by the
<code>simulate</code> function:</p>
<div class="sourceCode" id="cb44"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">Sim1</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/stats/simulate.html" class="external-link">simulate</a></span><span class="op">(</span></span>
<span>  object <span class="op">=</span> <span class="va">design2</span>, args <span class="op">=</span> <span class="cn">NULL</span>, trueDLE <span class="op">=</span> <span class="va">myTruthDLT</span>,</span>
<span>  trueEff <span class="op">=</span> <span class="va">myTruthEff</span>, trueNu <span class="op">=</span> <span class="fl">1</span> <span class="op">/</span> <span class="fl">0.025</span>, nsim <span class="op">=</span> <span class="fl">20</span>,</span>
<span>  seed <span class="op">=</span> <span class="fl">819</span>, parallel <span class="op">=</span> <span class="cn">FALSE</span></span>
<span><span class="op">)</span></span></code></pre></div>
<p>Note that the fixed precision <code>nu</code> <span class="math inline">\(1/\sigma^{2}\)</span> is specified instead of the
variance <span class="math inline">\(\sigma^{2}\)</span>. % The results
of the simulation can then be plotted and summarized as shown
before.</p>
</div>
<div class="section level3">
<h3 id="extending-crmpack-functionality">Extending crmPack functionality<a class="anchor" aria-label="anchor" href="#extending-crmpack-functionality"></a>
</h3>
<p>One of the big advantages of <code>crmPack</code> over existing
<code>R</code> implementations is its flexible framework based on the
<code>S4</code> classes and methods system <span class="citation">(Chambers 2008)</span> and <code>JAGS</code> <span class="citation">(Plummer 2003)</span> for Bayesian computations. Here
we will therefore illustrate how users can extend the existing
functionality easily to the specific needs of the study.</p>
<p><strong>Objective</strong> The example will implement a version of
the one-parameter CRM <span class="citation">(O’Quigley, Pepe, and
Fisher 1990)</span>, which is currently not (yet) included in the
package. It is based on a one-parameter power model to describe the
relationship between the binary DLT responses <span class="math inline">\(Y\)</span> and their corresponding dose levels
<span class="math inline">\(x\)</span>: <span class="math display">\[\begin{equation}
\label{eq:oneparameter}
\pi(x, \theta) = Prob(Y=1 | x, \theta) = f(x)^{\theta}
\end{equation}\]</span> Here <span class="math inline">\(0 &lt; f(x)
&lt; 1\)</span> is monotonically increasing in <span class="math inline">\(x\)</span> and is specified by the investigator
upfront. The sequence <span class="math inline">\(f(x_{1}), \dotsc,
f(x_{k})\)</span> along the dose grid is often called ``skeleton’’ of
the CRM. An exponential distribution with parameter <span class="math inline">\(\lambda\)</span> is imposed as the prior
distribution for the unknown parameter <span class="math inline">\(\theta\)</span>. The next dose should then be
chosen such that the distance of the posterior mean estimated DLT
probability to a predefined target toxicity level is minimized.</p>
<p><strong>Creating a new model</strong> To implement the one-parameter
model @<span class="math inline">\(\eqref{eq:oneparameter}\)</span> in
<code>crmPack</code> we first need to define an appropriate
<code>S4</code> class inheriting from the general model class
<code>GeneralModel</code>:</p>
<div class="sourceCode" id="cb45"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">.OneParExp</span> <span class="op">&lt;-</span> <span class="kw">setClass</span><span class="op">(</span></span>
<span>  Class <span class="op">=</span> <span class="st">"OneParExp"</span>,</span>
<span>  contains <span class="op">=</span> <span class="st">"GeneralModel"</span>,</span>
<span>  slots <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span></span>
<span>    skeleton_probs <span class="op">=</span> <span class="st">"numeric"</span>,</span>
<span>    dose_grid <span class="op">=</span> <span class="st">"numeric"</span>,</span>
<span>    lambda <span class="op">=</span> <span class="st">"numeric"</span></span>
<span>  <span class="op">)</span></span>
<span><span class="op">)</span></span></code></pre></div>
<p>Here we specify that the new class is called <code>OneParExp</code>
and contains three additional slots containing the resulting skeleton
prior probabilities, the dose grid, and the prior parameter <span class="math inline">\(\lambda\)</span>.</p>
<p>Second we have to create a convenient initialization function, which
specifies the likelihood and prior distributions in the underlying
<code>GeneralModel</code> in <code>JAGS</code>. We choose to let the
user supply just the skeleton probabilities along with the intended dose
grid to use. The likelihood with the power model is specified in
<code>datamodel</code> and uses the <code>Data</code> slots which are
specified in <code>datanames</code>. The prior is defined in
<code>priormodel</code>. Model parameters are passed to
<code>JAGS</code> via <code>modelspecs</code>. The <code>init</code>
slot contains a function giving the starting values for the MCMC
sampler, and <code>sample</code> defines which parameter samples will be
returned:</p>
<div class="sourceCode" id="cb46"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">OneParExp</span> <span class="op">&lt;-</span> <span class="kw">function</span><span class="op">(</span><span class="va">skeleton_probs</span>, <span class="va">dose_grid</span>, <span class="va">lambda</span><span class="op">)</span> <span class="op">{</span></span>
<span>  <span class="fu">.OneParExp</span><span class="op">(</span></span>
<span>    skeleton_probs <span class="op">=</span> <span class="va">skeleton_probs</span>,</span>
<span>    dose_grid <span class="op">=</span> <span class="va">dose_grid</span>,</span>
<span>    lambda <span class="op">=</span> <span class="va">lambda</span>,</span>
<span>    datamodel <span class="op">=</span> <span class="kw">function</span><span class="op">(</span><span class="op">)</span> <span class="op">{</span></span>
<span>      <span class="kw">for</span> <span class="op">(</span><span class="va">i</span> <span class="kw">in</span> <span class="fl">1</span><span class="op">:</span><span class="va">nObs</span><span class="op">)</span> <span class="op">{</span></span>
<span>        <span class="va">y</span><span class="op">[</span><span class="va">i</span><span class="op">]</span> <span class="op">~</span> <span class="fu">dbern</span><span class="op">(</span><span class="va">p</span><span class="op">[</span><span class="va">i</span><span class="op">]</span><span class="op">)</span></span>
<span>        <span class="va">p</span><span class="op">[</span><span class="va">i</span><span class="op">]</span> <span class="op">&lt;-</span> <span class="va">skeleton_probs</span><span class="op">[</span><span class="va">xLevel</span><span class="op">[</span><span class="va">i</span><span class="op">]</span><span class="op">]</span><span class="op">^</span><span class="va">theta</span></span>
<span>      <span class="op">}</span></span>
<span>    <span class="op">}</span>,</span>
<span>    priormodel <span class="op">=</span> <span class="kw">function</span><span class="op">(</span><span class="op">)</span> <span class="op">{</span></span>
<span>      <span class="va">theta</span> <span class="op">~</span> <span class="fu"><a href="https://rdrr.io/r/stats/Exponential.html" class="external-link">dexp</a></span><span class="op">(</span><span class="va">lambda</span><span class="op">)</span></span>
<span>    <span class="op">}</span>,</span>
<span>    modelspecs <span class="op">=</span> <span class="kw">function</span><span class="op">(</span><span class="op">)</span> <span class="op">{</span></span>
<span>      <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span>skeleton_probs <span class="op">=</span> <span class="va">skeleton_probs</span>, lambda <span class="op">=</span> <span class="va">lambda</span><span class="op">)</span></span>
<span>    <span class="op">}</span>,</span>
<span>    init <span class="op">=</span> <span class="kw">function</span><span class="op">(</span><span class="op">)</span> <span class="op">{</span></span>
<span>      <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span>theta <span class="op">=</span> <span class="fl">1</span><span class="op">)</span></span>
<span>    <span class="op">}</span>, sample <span class="op">=</span> <span class="st">"theta"</span>,</span>
<span>    datanames <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"nObs"</span>, <span class="st">"y"</span>, <span class="st">"xLevel"</span><span class="op">)</span></span>
<span>  <span class="op">)</span></span>
<span><span class="op">}</span></span></code></pre></div>
<p>Finally, we will create the <code>dose</code> and <code>prob</code>
methods. The <code>prob</code> method is based on the (a skeleton)
function which does the interpolation between the dose grid points in
order to obtain the probability of a DLT. The <code>dose</code>, on the
other hand, uses an inverse of (the skeleton) function <span class="math display">\[\begin{equation}
\label{eq:oneparameterInverse}
\pi^{-1}(p, \theta) = f^{-1}(p^{1/\theta})
\end{equation}\]</span> which maps the probability <span class="math inline">\(p\)</span> to a dose <span class="math inline">\(x\)</span>.</p>
<div class="sourceCode" id="cb47"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="kw">setMethod</span><span class="op">(</span></span>
<span>  f <span class="op">=</span> <span class="st">"dose"</span>,</span>
<span>  signature <span class="op">=</span> <span class="fu">signature</span><span class="op">(</span></span>
<span>    x <span class="op">=</span> <span class="st">"numeric"</span>,</span>
<span>    model <span class="op">=</span> <span class="st">"OneParExp"</span>,</span>
<span>    samples <span class="op">=</span> <span class="st">"Samples"</span></span>
<span>  <span class="op">)</span>,</span>
<span>  definition <span class="op">=</span> <span class="kw">function</span><span class="op">(</span><span class="va">x</span>, <span class="va">model</span>, <span class="va">samples</span><span class="op">)</span> <span class="op">{</span></span>
<span>    <span class="va">theta</span> <span class="op">&lt;-</span> <span class="va">samples</span><span class="op">@</span><span class="va">data</span><span class="op">$</span><span class="va">theta</span></span>
<span>    <span class="va">invSkeletonFun</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/stats/approxfun.html" class="external-link">approxfun</a></span><span class="op">(</span>x <span class="op">=</span> <span class="va">model</span><span class="op">@</span><span class="va">skeleton_probs</span>, y <span class="op">=</span> <span class="va">model</span><span class="op">@</span><span class="va">dose_grid</span>, rule <span class="op">=</span> <span class="fl">1</span><span class="op">)</span></span>
<span>    <span class="fu">invSkeletonFun</span><span class="op">(</span><span class="va">x</span><span class="op">^</span><span class="op">(</span><span class="fl">1</span> <span class="op">/</span> <span class="va">theta</span><span class="op">)</span><span class="op">)</span></span>
<span>  <span class="op">}</span></span>
<span><span class="op">)</span></span>
<span></span>
<span><span class="kw">setMethod</span><span class="op">(</span></span>
<span>  f <span class="op">=</span> <span class="st">"prob"</span>,</span>
<span>  signature <span class="op">=</span> <span class="fu">signature</span><span class="op">(</span></span>
<span>    dose <span class="op">=</span> <span class="st">"numeric"</span>,</span>
<span>    model <span class="op">=</span> <span class="st">"OneParExp"</span>,</span>
<span>    samples <span class="op">=</span> <span class="st">"Samples"</span></span>
<span>  <span class="op">)</span>,</span>
<span>  definition <span class="op">=</span> <span class="kw">function</span><span class="op">(</span><span class="va">dose</span>, <span class="va">model</span>, <span class="va">samples</span><span class="op">)</span> <span class="op">{</span></span>
<span>    <span class="va">theta</span> <span class="op">&lt;-</span> <span class="va">samples</span><span class="op">@</span><span class="va">data</span><span class="op">$</span><span class="va">theta</span></span>
<span>    <span class="va">skeletonFun</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/stats/approxfun.html" class="external-link">approxfun</a></span><span class="op">(</span>x <span class="op">=</span> <span class="va">model</span><span class="op">@</span><span class="va">dose_grid</span>, y <span class="op">=</span> <span class="va">model</span><span class="op">@</span><span class="va">skeleton_probs</span>, rule <span class="op">=</span> <span class="fl">2</span><span class="op">)</span></span>
<span>    <span class="fu">skeletonFun</span><span class="op">(</span><span class="va">dose</span><span class="op">)</span><span class="op">^</span><span class="va">theta</span></span>
<span>  <span class="op">}</span></span>
<span><span class="op">)</span></span></code></pre></div>
<p>Now we can already use the model, for example in the following we
specify the skeleton probabilities via the dose grid and use a standard
exponential prior for <span class="math inline">\(\theta\)</span>. The
resulting posterior fit can be plotted as usual, see Figure
@ref(fig:OneParExp-model-example).</p>
<div class="sourceCode" id="cb48"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="op">(</span><span class="va">skeleton_probs</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/base/Round.html" class="external-link">round</a></span><span class="op">(</span><span class="va">data</span><span class="op">@</span><span class="va">doseGrid</span> <span class="op">/</span> <span class="fu"><a href="https://rdrr.io/r/base/Extremes.html" class="external-link">max</a></span><span class="op">(</span><span class="va">data</span><span class="op">@</span><span class="va">doseGrid</span><span class="op">)</span> <span class="op">/</span> <span class="fl">2</span>, <span class="fl">2</span><span class="op">)</span><span class="op">)</span></span></code></pre></div>
<pre><code><span><span class="co">##  [1] 0.00 0.04 0.08 0.12 0.17 0.21 0.25 0.29 0.33 0.38 0.42 0.46 0.50</span></span></code></pre>
<div class="sourceCode" id="cb50"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">newModel</span> <span class="op">&lt;-</span> <span class="fu">OneParExp</span><span class="op">(</span></span>
<span>  skeleton_probs <span class="op">=</span> <span class="va">skeleton_probs</span>,</span>
<span>  dose_grid <span class="op">=</span> <span class="va">data</span><span class="op">@</span><span class="va">doseGrid</span>,</span>
<span>  lambda <span class="op">=</span> <span class="fl">1</span></span>
<span><span class="op">)</span></span>
<span><span class="va">newSamples</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/mcmc.html">mcmc</a></span><span class="op">(</span><span class="va">data</span>, <span class="va">newModel</span>, <span class="va">options</span><span class="op">)</span></span>
<span><span class="fu"><a href="https://rdrr.io/r/graphics/plot.default.html" class="external-link">plot</a></span><span class="op">(</span><span class="va">newSamples</span>, <span class="va">newModel</span>, <span class="va">data</span><span class="op">)</span></span></code></pre></div>
<div class="figure" style="text-align: center">
<img src="crmPack-jss-paper_files/figure-html/OneParExp-model-example-1.png" alt="Model fit of the one parameter power model" width=".5\linewidth"><p class="caption">
Model fit of the one parameter power model
</p>
</div>
<p><strong>Creating a new dose recommendation rule</strong> In a second
step we would like to create a new dose recommendation rule, which
proposes the dose with estimated DLT probability closest to the target.
Again we start with the class, now inheriting from
<code>NextBest</code>:</p>
<div class="sourceCode" id="cb51"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">.NextBestMinDist</span> <span class="op">&lt;-</span> <span class="kw">setClass</span><span class="op">(</span></span>
<span>  Class <span class="op">=</span> <span class="st">"NextBestMinDist"</span>,</span>
<span>  contains <span class="op">=</span> <span class="st">"NextBest"</span>,</span>
<span>  <span class="fu">representation</span><span class="op">(</span>target <span class="op">=</span> <span class="st">"numeric"</span><span class="op">)</span></span>
<span><span class="op">)</span></span>
<span><span class="va">NextBestMinDist</span> <span class="op">&lt;-</span> <span class="kw">function</span><span class="op">(</span><span class="va">target</span><span class="op">)</span> <span class="op">{</span></span>
<span>  <span class="fu"><a href="../reference/NextBestMinDist-class.html">.NextBestMinDist</a></span><span class="op">(</span>target <span class="op">=</span> <span class="va">target</span><span class="op">)</span></span>
<span><span class="op">}</span></span></code></pre></div>
<p>Note that here we keep to the convention of separate class definition
and initialization function, although there is no technical need in this
case. In order to make it usable we need to define the
<code>NextBest</code> method for this new rule. Note that we do only
specialize the method for the first argument, such that this rule could
also be used with other models.</p>
<div class="sourceCode" id="cb52"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="kw">setMethod</span><span class="op">(</span></span>
<span>  <span class="st">"nextBest"</span>,</span>
<span>  signature <span class="op">=</span> <span class="fu">signature</span><span class="op">(</span></span>
<span>    nextBest <span class="op">=</span> <span class="st">"NextBestMinDist"</span>,</span>
<span>    doselimit <span class="op">=</span> <span class="st">"numeric"</span>,</span>
<span>    samples <span class="op">=</span> <span class="st">"Samples"</span>,</span>
<span>    model <span class="op">=</span> <span class="st">"OneParExp"</span>,</span>
<span>    data <span class="op">=</span> <span class="st">"Data"</span></span>
<span>  <span class="op">)</span>,</span>
<span>  def <span class="op">=</span> <span class="kw">function</span><span class="op">(</span><span class="va">nextBest</span>, <span class="va">doselimit</span>, <span class="va">samples</span>, <span class="va">model</span>, <span class="va">data</span>, <span class="va">...</span><span class="op">)</span> <span class="op">{</span></span>
<span>    <span class="va">dosesOK</span> <span class="op">&lt;-</span></span>
<span>      <span class="kw">if</span> <span class="op">(</span><span class="fu"><a href="https://rdrr.io/r/base/length.html" class="external-link">length</a></span><span class="op">(</span><span class="va">doselimit</span><span class="op">)</span><span class="op">)</span> <span class="op">{</span></span>
<span>        <span class="fu"><a href="https://rdrr.io/r/base/which.html" class="external-link">which</a></span><span class="op">(</span><span class="va">data</span><span class="op">@</span><span class="va">doseGrid</span> <span class="op">&lt;=</span> <span class="va">doselimit</span><span class="op">)</span></span>
<span>      <span class="op">}</span> <span class="kw">else</span> <span class="op">{</span></span>
<span>        <span class="fu"><a href="https://rdrr.io/r/base/seq.html" class="external-link">seq_along</a></span><span class="op">(</span><span class="va">data</span><span class="op">@</span><span class="va">doseGrid</span><span class="op">)</span></span>
<span>      <span class="op">}</span></span>
<span>    <span class="va">modelfit</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/fit.html">fit</a></span><span class="op">(</span><span class="va">samples</span>, <span class="va">model</span>, <span class="va">data</span><span class="op">)</span></span>
<span>    <span class="va">probDLT</span> <span class="op">&lt;-</span> <span class="va">modelfit</span><span class="op">$</span><span class="va">middle</span><span class="op">[</span><span class="va">dosesOK</span><span class="op">]</span></span>
<span>    <span class="va">doses</span> <span class="op">&lt;-</span> <span class="va">modelfit</span><span class="op">$</span><span class="va">dose</span><span class="op">[</span><span class="va">dosesOK</span><span class="op">]</span></span>
<span>    <span class="va">bestIndex</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/base/which.min.html" class="external-link">which.min</a></span><span class="op">(</span><span class="fu"><a href="https://rdrr.io/r/base/MathFun.html" class="external-link">abs</a></span><span class="op">(</span><span class="va">probDLT</span> <span class="op">-</span> <span class="va">nextBest</span><span class="op">@</span><span class="va">target</span><span class="op">)</span><span class="op">)</span></span>
<span>    <span class="va">bestDose</span> <span class="op">&lt;-</span> <span class="va">doses</span><span class="op">[</span><span class="va">bestIndex</span><span class="op">]</span></span>
<span>    <span class="kw"><a href="https://rdrr.io/r/base/function.html" class="external-link">return</a></span><span class="op">(</span><span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span>value <span class="op">=</span> <span class="va">bestDose</span><span class="op">)</span><span class="op">)</span></span>
<span>  <span class="op">}</span></span>
<span><span class="op">)</span></span></code></pre></div>
<p>In the method definition, we can use the <code>fit</code> function in
order to obtain the estimated DLT rates. We need to return a
<code>list</code> from this method, since this is required by the
generic function definition. The advantage is that we could also include
a plot or other supporting information in the return value. Immediately
we can now use this rule in order to obtain the next dose
recommendation, e.g., after specifying a target dose of 30%:</p>
<div class="sourceCode" id="cb53"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">newMyNextBest</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/NextBestMinDist-class.html">NextBestMinDist</a></span><span class="op">(</span>target <span class="op">=</span> <span class="fl">0.3</span><span class="op">)</span></span>
<span><span class="va">newNextDoseVal</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/nextBest.html">nextBest</a></span><span class="op">(</span><span class="va">newMyNextBest</span>, <span class="va">nextMaxDose</span>, <span class="va">newSamples</span>, <span class="va">newModel</span>, <span class="va">data</span><span class="op">)</span><span class="op">$</span><span class="va">value</span></span>
<span><span class="va">newNextDoseVal</span></span></code></pre></div>
<pre><code><span><span class="co">## [1] 150</span></span></code></pre>
<p>So using this CRM, we could escalate to 150 mg, instead of just
100 mg above.</p>
<p><strong>Using the new functionality</strong> These were the only
necessary additions of code that we needed to implement the
one-parameter CRM with a greedy next best dose rule - from now on we can
use the new classes in the same way as classes already contained in
<code>crmPack</code>! For example, we can create a corresponding new
<code>Design</code> object, examine its hypothetical trial course and
run simulations. In particular, the placebo convention automatically
carries over.</p>
</div>
</div>
<div class="section level2">
<h2 id="summary">Summary<a class="anchor" aria-label="anchor" href="#summary"></a>
</h2>
<p>In this paper we have introduced the <code>R</code> package
<code>crmPack</code> for analyzing and evaluating dose escalation
trials. Unlike existing software the package is written to make full use
of a class structure enabling easy extensions to user-specific
dose-response models, prior distributions, escalation and stopping
rules. The example in <a href="#extending-crmpack-functionality">Extending crmPack
functionality</a> demonstrated that:</p>
<ol style="list-style-type: decimal">
<li>New functionality can be added - without changing the package.</li>
<li>Only the new functionality needs to be coded in one place - no side
effects need to be considered.</li>
<li>Templates for new designs can be found by looking at the existing
code in the package - only minimal <code>S4</code> and <code>JAGS</code>
knowledge is required.</li>
</ol>
<p>Therefore, <code>crmPack</code> allows the user to easily extend the
package by keeping modifications local and limited to what needs to be
changed, which in our experience has been a key success factor for the
wider use of model-based dose escalation designs. The package does,
however, already include a wide range of model-based and algorithmic
dose escalation procedures, which are described in the package’s
documentation available through <code><a href="../reference/crmPackHelp.html">crmPackHelp()</a></code> and provide
end-users easy access to these approaches without the need for further
coding. Another unique feature of the package is the inclusion of
approaches that allow placebo data, which are routinely collected in
healthy volunteer studies, to be utilized. Finally some methods
[e.g.,]<span class="citation">(Bekele and Shen 2005)</span><span class="citation">(Yeung et al. 2015)</span> for dose-finding
incorporating safety and efficacy are implemented already in the
package. As for all designs, the underlying structure to extend to novel
dual endpoint methods is provided. Simulation facilities for all
approaches and relevant graphical displays are also available.</p>
<p>The package is actively developed further and new methods will be
added. Future extensions of <code>crmPack</code> will include
model-based combination dose escalation designs, see for example <span class="citation">(M. J. Sweeting and Mander 2012)</span> and [<span class="citation">Riviere et al. (2014)</span> for recent reviews.
Furthermore, data-augmentation CRM designs [see]<span class="citation">(Liu and Ning 2013)</span> that allow for a decoupling
of inter-cohort waiting times and DLT time windows, hence speeding up
dose escalation trials, will be included.</p>
</div>
<div class="section level2">
<h2 id="acknowledgments">Acknowledgments<a class="anchor" aria-label="anchor" href="#acknowledgments"></a>
</h2>
<p>We would like to thank Francesca Michielin and Peter Dutton for their
valuable comments on an earlier draft of the manuscript. This report is
funded by the Roche Postdoctoral Fellowship programme (RPF-234) and
research arising from Prof Jaki’s Senior Research Fellowship
(NIHR-SRF-2015-08-001) supported by the National Institute for Health
Research. The views expressed in this publication are those of the
authors and not necessarily those of the NHS, the National Institute for
Health Research or the Department of Health. This manuscript was
prepared using <code>knitr</code> <span class="citation">(Xie
2018)</span>.</p>
</div>
<div class="section level2">
<h2 class="unnumbered" id="references">References<a class="anchor" aria-label="anchor" href="#references"></a>
</h2>
<div id="refs" class="references csl-bib-body hanging-indent" entry-spacing="0">
<div id="ref-bekele2005" class="csl-entry">
Bekele, NB, and Yu Shen. 2005. <span>“A Bayesian Approach to Jointly
Modeling Toxicity and Biomarker Expression in a Phase i/II Dose-Finding
Trial.”</span> <em>Biometrics</em> 61 (2): 343–54.
</div>
<div id="ref-carter1973" class="csl-entry">
Carter, STEPHEN K. 1973. <span>“Study Design Principles for the Clinical
Evaluation of New Drugs as Developed by the Chemotherapy Programme of
the National Cancer Institute.”</span> <em>The Design of Clinical Trials
in Cancer Therapy</em> 1: 242–89.
</div>
<div id="ref-Chambers2008" class="csl-entry">
Chambers, John. 2008. <em>Software for Data Analysis</em>. Statistics
and Computing. Springer-Verlag.
</div>
<div id="ref-dfcrm2013" class="csl-entry">
Cheung, Ken. 2013. <em>: Dose-Finding by the Continual Reassessment
Method</em>. <a href="https://www.routledge.com/Dose-Finding-by-the-Continual-Reassessment-Method/Cheung/p/book/9781420091519" class="external-link">https://www.routledge.com/Dose-Finding-by-the-Continual-Reassessment-Method/Cheung/p/book/9781420091519</a>.
</div>
<div id="ref-cheung2000" class="csl-entry">
Cheung, Ying Kuen, and Rick Chappell. 2000. <span>“Sequential Designs
for Phase i Clinical Trials with Late-Onset Toxicities.”</span>
<em>Biometrics</em> 56 (4): 1177–82.
</div>
<div id="ref-R2016" class="csl-entry">
Core Team. 2016. <em>: A Language and Environment for Statistical
Computing</em>. Vienna, Austria: Foundation for Statistical Computing.
<a href="https://www.R-project.org/" class="external-link">https://www.R-project.org/</a>.
</div>
<div id="ref-East2016" class="csl-entry">
Cytel Inc. 2016.<em> 6: Statistical Software for the Design, Simulation
and Monitoring of Clinical Trials</em>. Cambridge, MA. <a href="http://www.cytel.com/software/east/" class="external-link">http://www.cytel.com/software/east/</a>.
</div>
<div id="ref-ordcrm" class="csl-entry">
Dressler, Emily V., and Zhengyan Huang. 2016. <em>: Likelihood-Based
Continual Reassessment Method (CRM) Dose Finding Designs</em>. <a href="https://CRAN.R-project.org/package=ordcrm" class="external-link">https://CRAN.R-project.org/package=ordcrm</a>.
</div>
<div id="ref-FACTS" class="csl-entry">
FACTS Development Team. 2015. <em>Fixed and Adaptive Clinical Trial
Simulator</em>. <a href="http://www.berryconsultants.com/software" class="external-link">http://www.berryconsultants.com/software</a>.
</div>
<div id="ref-Addplan2016" class="csl-entry">
ICON Plc. 2016. <em>: Adaptive Design Trials Software</em>. Dublin,
Ireland. <a href="http://www.iconplc.com/innovation/addplan/" class="external-link">http://www.iconplc.com/innovation/addplan/</a>.
</div>
<div id="ref-SAS2003" class="csl-entry">
Institute Inc. 2003.<em> Software, Version 9.1</em>. Cary, NC. <a href="http://www.sas.com/" class="external-link">http://www.sas.com/</a>.
</div>
<div id="ref-jaki2013" class="csl-entry">
Jaki, Thomas, Sally Clive, and Christopher J Weir. 2013.
<span>“Principles of Dose Finding Studies in Cancer: A Comparison of
Trial Designs.”</span> <em><span>Cancer Chemotherapy and
Pharmacology</span></em> 71 (5): 1107–14.
</div>
<div id="ref-Liu2013" class="csl-entry">
Liu, Suyu, and Jing Ning. 2013. <span>“A Bayesian Dose-Finding Design
for Drug Combination Trials with Delayed Toxicities.”</span>
<em>Bayesian Analysis</em> 8 (3): 703–22.
</div>
<div id="ref-StataCRM" class="csl-entry">
Mander, Adrian. 2013. <em>: Stata Module to Implement the Continual
Reassessment Model</em>. <a href="https://ideas.repec.org/c/boc/bocode/s457625a.html" class="external-link">https://ideas.repec.org/c/boc/bocode/s457625a.html</a>.
</div>
<div id="ref-Neuenschwander2008" class="csl-entry">
Neuenschwander, Beat, Michael Branson, and Thomas Gsponer. 2008.
<span>“Critical Aspects of the Bayesian Approach to Phase i Cancer
Trials.”</span> <em><span>Statistics in Medicine</span></em> 27 (13):
2420–39.
</div>
<div id="ref-oquigley1990" class="csl-entry">
O’Quigley, John, Margaret Pepe, and Lloyd Fisher. 1990. <span>“Continual
Reassessment Method: A Practical Design for Phase 1 Clinical Trials in
Cancer.”</span> <em>Biometrics</em> 46 (1): 33–48.
</div>
<div id="ref-Paoletti2015" class="csl-entry">
Paoletti, X., M. Ezzalfani, and C. Le Tourneau. 2015. <span>“Statistical
Controversies in Clinical Research: Requiem for the 3 + 3 Design for
Phase i Trials.”</span> <em>Annals of Oncology</em> 26 (9): 1808–12.
</div>
<div id="ref-JAGS" class="csl-entry">
Plummer, Martyn. 2003. <em>: A Program for Analysis of Bayesian
Graphical Models Using Gibbs Sampling</em>. <a href="http://mcmc-jags.sourceforge.net" class="external-link">http://mcmc-jags.sourceforge.net</a>.
</div>
<div id="ref-Riviere2014" class="csl-entry">
Riviere, M.- K., C. Le Tourneau, X. Paoletti, F. Dubois, and S. Zohar.
2014. <span>“Designs of Drug-Combination Phase i Trials in Oncology: A
Systematic Review of the Literature.”</span> <em>Annals of Oncology</em>
26 (4): 669–74.
</div>
<div id="ref-crmPack" class="csl-entry">
Sabanes Bove, Daniel, Wai Yin Yeung, Giuseppe Palermo, and Thomas Jaki.
2018. <em>: Object-Oriented Implementation of CRM Designs</em>. <a href="http://CRAN.R-project.org/package=crmPack" class="external-link">http://CRAN.R-project.org/package=crmPack</a>.
</div>
<div id="ref-Stata2015" class="csl-entry">
StataCorp. 2015.<em> Statistical Software: Release 14</em>. College
Station, TX: StataCorp LP. <a href="http://www.stata.com/" class="external-link">http://www.stata.com/</a>.
</div>
<div id="ref-Storer1989" class="csl-entry">
Storer, Barry E. 1989. <span>“<a href="https://www.ncbi.nlm.nih.gov/pubmed/2790129" class="external-link">Design and Analysis
of Phase i Clinical Trials</a>.”</span> <em>Biometrics</em> 45 (3):
925–37.
</div>
<div id="ref-Sweeting2012" class="csl-entry">
Sweeting, Michael J, and Adrian P Mander. 2012. <span>“Escalation
Strategies for Combination Therapy Phase i Trials.”</span>
<em>Pharmaceutical Statistics</em> 11 (3).
</div>
<div id="ref-sweeting2013" class="csl-entry">
Sweeting, Michael, Adrian Mander, and Tony Sabin. 2013. <span>“:
Bayesian Continual Reassessment Method Designs for Phase i Dose-Finding
Trials.”</span> <em>Journal of Statistical Software</em> 54 (13): 1–26.
</div>
<div id="ref-Thall2010" class="csl-entry">
Thall, Peter F. 2010. <span>“<a href="https://www.ncbi.nlm.nih.gov/pubmed/21318084" class="external-link">Bayesian Models and
Decision Algorithms for Complex Early Phase Clinical Trials</a>.”</span>
<em>Statistical Science</em> 25 (2): 227–44.
</div>
<div id="ref-dfpk" class="csl-entry">
Toumazi, Artemis, Moreno Ursino, and Sarah Zohar. 2017. <em>: A Bayesian
Dose-Finding Design Using Pharmacokinetics (PK) for Phase i Clinical
Trials</em>. <a href="https://CRAN.R-project.org/package=dfpk" class="external-link">https://CRAN.R-project.org/package=dfpk</a>.
</div>
<div id="ref-w06" class="csl-entry">
Whitehead, J. 2006. <span>“Statistical Methods for Dose-Finding
Experiments.”</span> In, edited by Sylvie Chevret. John Wiley &amp;
Sons.
</div>
<div id="ref-ggplot2" class="csl-entry">
Wickham, Hadley. 2009. <em>: Elegant Graphics for Data Analysis</em>.
Springer-Verlag. <a href="http://ggplot2.org" class="external-link">http://ggplot2.org</a>.
</div>
<div id="ref-knitr2018" class="csl-entry">
Xie, Yihui. 2018. <em>: A General-Purpose Package for Dynamic Report
Generation in r</em>. <a href="https://yihui.name/knitr/" class="external-link">https://yihui.name/knitr/</a>.
</div>
<div id="ref-yeung2015" class="csl-entry">
Yeung, Wai Yin, John Whitehead, Bruno Reigner, Ulrich Beyer, Cheikh
Diack, and Thomas Jaki. 2015. <span>“Bayesian Adaptive Dose-Escalation
Procedures for Binary and Continuous Responses Utilizing a Gain
Function.”</span> <em><span>Pharmaceutical Statistics</span></em> 14
(6): 479–87.
</div>
</div>
</div>
  </main><aside class="col-md-3"><nav id="toc"><h2>On this page</h2>
    </nav></aside>
</div>



    <footer><div class="pkgdown-footer-left">
  <p>Developed by Daniel Sabanes Bove, Wai Yin Yeung, Burak Kuersad Guenhan, Giuseppe Palermo, Thomas Jaki, Jiawen Zhu, Ziwei Liao, Dimitris Kontos, Marlene Schulte-Goebel, Doug Kelkhoff, Oliver Boix, Robert Adams, Clara Beck, John Kirkpatrick, F. Hoffmann-La Roche AG, Merck Healthcare KGaA, Bayer AG.</p>
</div>

<div class="pkgdown-footer-right">
  <p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.0.9.</p>
</div>

    </footer>
</div>

  

  

  </body>
</html>
